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ABOUT A REVOLUTION: TOWARD
INTEGRATED TREATMENT IN DRUG AND
MENTAL HEALTH COURTS*
SARA GORDON**
This Article examines specialty courts, including drug, alcohol,
and mental health courts, which proponents claim created a
revolution in criminal justice. Defendants whose underlying
crime is the result of a substance use disorder or a mental health
disorder can choose to be diverted into a specialty court, where
they receive treatment instead of punishment. Many of these
individuals, however, do not just suffer from a substance use
disorder or a mental health disorder; instead, many have a “cooccurring disorder.” Approximately 8.9 million American adults
have co-occurring mental health and substance use disorders,
and almost half of individuals who meet diagnostic criteria for
one disorder will also meet criteria for the other. Moreover, an
extensive body of literature has shown that treatment for cooccurring disorders should be integrated and that individuals
should receive appropriate mental health and substance abuse
treatment from a single clinician or clinical team.
This Article argues that the segregation of drug, alcohol, and
mental health courts is out of step with our current understanding
of the high rates of co-occurring disorders, and often fails to
provide integrated treatment for the multiple disorders a single
specialty-court participant might present. Moreover, by
segregating specialty courts, we are further stigmatizing addiction
and failing to acknowledge that drug and alcohol use disorders
are some of the many types of mental illnesses recognized by the
medical community. Drug, alcohol, and mental health courts
should therefore move away from their traditional siloed
approach to the selection and treatment of participants and
instead provide individuals with comprehensive and integrated
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INTRODUCTION
I didn’t realize I actually had post-traumatic stress disorder at the
time, but why would I think I had that? Anyway, how would I
know which was post-traumatic stress, which is addiction, which
is bipolar, which is Libra?1
Although she is perhaps best known as Princess Leia, the actress
Carrie Fisher also spoke openly about her history of addiction and
mental illness and “once joked that she wanted to start a ‘Bipolar
Pride Day’ to help erase the stigma of the disease.”2 When she died in
December 2016 after suffering a heart attack on a flight to Los
Angeles, many of her fans remembered Fisher not only for her career
as an actress, author, and screenwriter but also for her nearly life-long
struggle with what mental health professionals describe as a “co-

1. CARRIE FISHER, WISHFUL DRINKING 143 (2008).
2. Ryan Burleson & Tara Parker-Pope, Fans Tweet About Mental Illness to Honor
Carrie Fisher, N.Y. TIMES (Dec. 27, 2016), https://www.nytimes.com/2016/12/27/arts/carriefisher-bipolar-disorder.html [https://perma.cc/ZM38-K4BG (dark archive)]. At the
beginning of her memoir, Fisher notes that if her life were not funny, “it would just be
true, and that is unacceptable.” FISHER, supra note 1, at 17. She describes “Bipolar Pride
Day” this way: “You know, with floats and parades and stuff! On the floats we would get
the depressives, and they wouldn’t even have to leave their beds. . . . And then for the
manics, we’d have the manic marching band. . . .” Id. at 127.
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occurring disorder,” or a diagnosis of at least one mental health
condition and one substance use disorder.3
As Fisher described it: “I used to think I was a drug addict, pure
and simple—just someone who could not stop taking drugs willfully.
. . . And I was that. But it turns out that I am severely manic
depressive.”4 Fisher started using drugs around the age of thirteen,5
continued taking drugs like LSD and Percodan during the 1970s and
1980s,6 and admitted to a reporter that she “did cocaine on the set of
[The] Empire [Strikes Back], in the ice planet . . . .”7 In 1985, after
filming a role in the Woody Allen film Hannah and Her Sisters, she
nearly overdosed and entered an inpatient rehabilitation facility in
Los Angeles.8 When she died in 2016, an autopsy found cocaine,
methadone, heroin, and MDMA in her system.9 In addition to illegal
substances, Fisher was taking Lamictal, a commonly prescribed
bipolar medication, along with the antidepressants Prozac and
3. Burleson & Parker-Pope, supra note 2 (“Legions of fans seemed to grant her wish
on Tuesday in the hours after her death at age 60. One after another, in words both plainspoken and deeply personal, admirers paid tribute to Ms. Fisher by ‘coming out’ on
Twitter with their own stories of mental illness.”); see also U.S. DEP’T OF HEALTH &
HUM. SERVS., SUBSTANCE ABUSE TREATMENT FOR PERSONS WITH CO-OCCURRING
DISORDERS: A TREATMENT IMPROVEMENT PROTOCOL TIP 42, at 3 (2013) [hereinafter
TIP], https://store.samhsa.gov/file/23170/download?token=FBHtrcSs [https://perma.cc/W5FUZCPP (staff-uploaded archive)] (“Clients said to have co-occurring disorders have one or
more disorders relating to the use of alcohol and/or other drugs of abuse as well as one or
more mental disorders.”); Mary Ann Priester et al., Treatment Access Barriers and
Disparities Among Individuals with Co-Occurring Mental Health and Substance Use
Disorders: An Integrative Literature Review, 61 J. SUBSTANCE ABUSE TREATMENT 47, 47
(2016) (“[A] diagnosis of [a co-occurring disorder] requires that at least one mental illness
and one substance use disorder (SUD) must be able to be diagnosed independently.”).
4. PrimeTime: Carrie Fisher Interview, ABC NEWS (Dec. 21, 2000),
https://abcnews.go.com/Primetime/story?id=132315&page=1 [https://perma.cc/Q8N2-FY32].
5. FISHER, supra note 1, at 131.
6. Dave Itzkoff, Carrie Fisher, Child of Hollywood and ‘Star Wars’ Royalty, Dies at
60, N.Y. TIMES (Dec. 27, 2016), https://www.nytimes.com/2016/12/27/movies/carrie-fisherdead-star-wars-princess-leia.html [https://perma.cc/7LRL-7ASA (dark archive)].
7. Ben Child, Carrie Fisher Admits Taking Cocaine on Set of The Empire Strikes
Back, GUARDIAN (Oct. 12, 2010), https://www.theguardian.com/film/2010/oct/12/carriefisher-cocaine-star-wars [https://perma.cc/YMF6-DE3Y].
8. Itzkoff, supra note 6.
9. Gene Maddaus, Carrie Fisher Had Cocaine, Heroin, Ecstasy in Her System,
Autopsy Shows, VARIETY (June 19, 2017, 9:15 AM), https://variety.com/2017/biz/news/
carrie-fisher-autopsy-cocaine-heroin-ecstasy-1202470282/ [https://perma.cc/G7CN-K23A]
(“The coroner’s report listed sleep apnea as the primary cause of death, with drug intake
as a contributing factor. . . . Fisher died on Dec. 27, four days after going into cardiac arrest
on an airplane arriving at LAX from London. The report states that Fisher’s assistant was
on the plane with her. The assistant reported that she was awake and normal at the
beginning of the flight, but had ‘multiple apneic episodes, which was her baseline’ during
the flight. At the end of the flight, she could not be awoken.”).
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Abilify.10 In her memoir, Fisher described her bipolar states by name:
Rollicking Roy, “the wild ride of a mood,” and Sediment Pam, “who
stands on the shore and sobs.”11
Although Fisher is a well-known example of a person with both a
substance use disorder and a mental health disorder, this type of
diagnosis is not uncommon. Like Fisher, when an individual meets
clinical criteria for both a substance use disorder and a mental health
disorder, that person is said to have a co-occurring disorder, or a
“dual-diagnosis.”12 Approximately 8.9 million American adults have
co-occurring mental health and substance use disorders,13 and “the
services of the mental health and substance abuse treatment systems
will be needed by a substantial number of Americans at one time or
another in their lifetime.”14 Rates of co-occurring disorders are high
because addiction often occurs concurrently with or contributes to
many different medical conditions, including physical conditions like
heart disease,15 as well as mental health and behavioral disorders like
depression and anxiety.16 In fact, a major risk factor for addiction is
the presence of mental illness.17
Addiction and mental illness also share a painful history in which
people with one or both diagnoses “endured institutions that offered
no treatment, ineffective treatment, or well-intentioned treatment
that did harm.”18 Because of historical stigmatization, some
individuals with substance use disorders, mental health disorders, or
10. Id.
11. FISHER, supra note 1, at 121 (“One mood is the meal and the next mood is the
check.”).
12. Priester et al., supra note 3, at 47; see also TIP, supra note 3, at 3.
13. Priester et al., supra note 3, at 47.
14. Stanley Sacks, Redonna Chandler & Junius Gonzales, Responding to the
Challenge of Co-Occurring Disorders: Suggestions for Future Research, 34 J. SUBSTANCE
ABUSE TREATMENT 139, 140 (2008).
15. See Mental Health and Heart Health, AM. HEART ASS’N (Apr. 18, 2018),
https://www.heart.org/en/healthy-living/healthy-lifestyle/mental-health-and-wellbeing/mentalhealth-and-heart-health [https://perma.cc/5KD7-8M4H].
16. See Kathleen T. Brady & Rajita Sinha, Co-Occurring Mental and Substance Use
Disorders: The Neurobiological Effects of Chronic Stress, 162 AM. J. PSYCHIATRY 1483,
1483 (2005) (“The high rate of co-occurrence of substance use disorders and other
psychiatric disorders is well established.”).
17. M. Tyler Boden & Rudolf Moos, Dually Diagnosed Patients’ Responses to
Substance Use Disorder Treatment, 37 J. SUBSTANCE ABUSE TREATMENT 335, 335 (2009)
(“The prevalence of psychiatric disorders among individuals with substance use disorders
(SUDs) is quite high, with estimates ranging from 18% to 70% among those seeking
treatment for SUDs.”).
18. Larry Davidson & William White, The Concept of Recovery as an Organizing
Principle for Integrating Mental Health and Addiction Services, 34 J. BEHAV. HEALTH
SERVS. & RES. 109, 110 (2007).
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some combination of the two first receive treatment as a result of
their involvement with the criminal justice system. A recent study by
the Department of Justice assessed over one million state prison,
federal prison, and local jail inmates for mental health problems and
found that 55% of all inmates had “a recent history or symptoms of a
mental health problem” that had occurred in the previous twelve
months.19 Moreover, among inmates with a mental health problem,
between 64% and 76% had a co-occurring substance use disorder.20
Those with mental health problems were also more likely to abuse
illegal drugs and alcohol and to have a family history of substance
abuse.21
While all federal penitentiaries and most state prisons and jails
do provide some mental health services to inmates,22 many other
individuals first enter into treatment after they have been arrested
and diverted to a specialty court. The first specialty courts were drug
courts, which were created to provide treatment and services to
individuals whose involvement with the criminal justice system was
likely due to an underlying addiction.23 The first drug court was
established in Florida in 1989, and today there are over 2500 drug
courts across every state in the country.24 As the drug court model
grew in popularity, states began establishing other specialty courts,

19. DORIS J. JAMES & LAUREN E. GLAZE, MENTAL HEALTH PROBLEMS OF PRISON
AND JAIL INMATES 1 (Tina Dorsey et al. eds., 2006) (“At midyear 2005 more than half of
all prison and jail inmates had a mental health problem, including 705,600 inmates in State
prisons, 78,800 in Federal prisons, and 479,900 in local jails. These estimates represented
56% of State prisoners, 45% of federal prisoners, and 64% of jail inmates. The findings in
this report were based on data from personal interviews with State and Federal prisoners
in 2004 and local jail inmates in 2002.”).
20. Id. at 6 (“Among inmates who had a mental health problem, local jail inmates had
the highest rate of dependence or abuse of alcohol or drugs (76%), followed by State
prisoners (74%), and Federal prisoners (64%) . . . . Substance dependence or abuse was
measured as defined in the DSM-IV. Among inmates without a mental health problem,
56% in State prisons, 49% in Federal prisons, and 53% in local jails were dependent on or
abused alcohol or drugs.”).
21. Id. at 6 tbl.6.
22. Id. at 9 (“State prisoners who had a mental health problem (34%) had the highest
rate of mental health treatment since admission, followed by federal prisoners (24%) and
local jail inmates (17%).”).
23. RYAN S. KING & JILL PASQUARELLA, THE SENTENCING PROJECT, DRUG
COURTS: A REVIEW OF THE EVIDENCE 1 (2009), http://www.sentencingproject.org/wpcontent/uploads/2016/01/Drug-Courts-A-Review-of-the-Evidence.pdf [https://perma.cc/H45FK2P2].
24. Id.; see also JUSTICE POLICY INST., ADDICTED TO COURTS: HOW A GROWING
DEPENDENCE ON DRUG COURTS IMPACTS PEOPLE AND COMMUNITIES 18–20 (2011),
http://www.justicepolicy.org/uploads/justicepolicy/documents/addicted_to_courts_final.pdf
[https://perma.cc/5AV2-SV37].
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including mental health courts,25 as well as alcohol and driving while
intoxicated (“DWI”) courts.26
These specialty courts offer would-be defendants “the choice of
participating in an intensive court-monitored treatment program as
an alternative to the normal adjudication process.”27 As this Article
will explore, however, not all specialty courts are created equal.
Unlike drug and alcohol courts, which focus on drug- and alcoholrelated charges and often have a more punitive focus,28 mental health
courts are often described as “treatment courts” and have the stated
goal of connecting participants to available community resources.29
Furthermore, this segregated specialty court model is out of step with
our current understanding of both the nature of the disease of
addiction, as well as the existence of high rates of co-occurring
disorders. As a result, these segregated courts perpetuate the stigma
surrounding addiction by categorizing individuals with a substance
use disorder differently than individuals with a broader mental health
disorder. Moreover, both drug and mental health courts often fail to
provide appropriate treatment for the multiple disorders a single

25. Other specialty courts include tribal courts, reentry courts, DWI courts, juvenile
drug courts, domestic violence courts, truancy courts, prostitution courts, and
homelessness courts, among others. JUSTICE POLICY INST., supra note 24, at 18–20; see
also WEST HUDDLESTON & DOUGLAS B. MARLOWE, U.S. DEP’T OF JUSTICE, PAINTING
THE CURRENT PICTURE: A NATIONAL REPORT ON DRUG COURTS AND OTHER
PROBLEM-SOLVING COURT PROGRAMS IN THE UNITED STATES 68 (2011),
http://www.ndci.org/sites/default/files/nadcp/PCP%20Report%20FINAL.PDF [https://perma.cc/
WH65-WD7Y] (“The extraordinary success of Adult Drug Courts has produced a wide
variety of other types of Drug Court programs.”).
26. SUZANNE M. STRONG, RAMONA R. RANTALA & TRACEY KYCKELLHAHN, U.S.
DEP’T OF JUSTICE, CENSUS OF PROBLEM-SOLVING COURTS, 2012, at 1 (2016),
https://www.bjs.gov/content/pub/pdf/cpsc12.pdf [https://perma.cc/5EZ3-GDUW].
27. JAMES L. NOLAN, JR., REINVENTING JUSTICE: THE AMERICAN DRUG COURT
MOVEMENT 5 (2001).
28. Patricia A. Griffin, Henry J. Steadman & John Petrila, The Use of Criminal
Charges and Sanctions in Mental Health Courts, 53 PSYCHIATRIC SERVS. 1285, 1288
(2002) (“The use of punishment is considered a core feature of drug courts and is used
routinely in that setting.”); see also U.S. DEP’T OF JUSTICE, MENTAL HEALTH COURTS: A
PRIMER FOR POLICYMAKERS & PRACTITIONERS 9 (2008), https://csgjusticecenter.org/wpcontent/uploads/2012/12/mhc-primer.pdf [https://perma.cc/VH7M-33UG] (noting the
difference between drug courts and mental health courts).
29. LAUREN ALMQUIST & ELIZABETH DODD, COUNCIL OF STATE GOV’TS JUSTICE
CTR., MENTAL HEALTH COURTS: A GUIDE TO RESEARCH-INFORMED POLICY AND
PRACTICE 2 (2009), https://www.bja.gov/Publications/CSG_MHC_Research.pdf [https://perma.cc/
9FVV-H42F] (citing several studies and observing that “[m]ental health courts have several
goals: to improve public safety by reducing the recidivism rates of people with mental
illnesses, to reduce corrections costs by providing alternatives to incarceration, and to
improve the quality of life of people with mental illnesses by connecting them with
treatment and preventing re-involvement in the criminal justice system”).

97 N.C. L. REV. 355 (2019)

2019]

ABOUT A REVOLUTION

361

individual might present. This Article argues that drug, alcohol, and
mental health courts should move away from their traditional, siloed
approach to the selection and treatment of participants and instead
provide individuals with comprehensive, evidence-based treatment
for co-occurring substance use and mental health disorders.
Part I of this Article examines the evolution of the current
specialty court model, including the historical forces that helped
create the current siloed approach to treatment. This Part also
considers some of the obstacles to the provision of integrated
treatment for co-occurring mental health and substance use disorders.
Part II discusses contemporary scientific understanding of the disease
of addiction and its diagnosis. Part III explores the prevalence of cooccurring disorders, focusing particularly on the rates of co-occurring
substance use and mental health disorders. Part IV describes current
best practices for treatment of individuals with co-occurring disorders,
as well as the significant dearth of training opportunities for
treatment providers. Finally, Part V examines the role of specialty
courts in the provision of treatment services for co-occurring mental
health and substance use disorders. This Part argues that drug,
alcohol, and mental health courts should be integrated both because
substance use disorder is a mental illness that should no longer be
relegated to the fringes of the mental health system and because cooccurring disorders in specialty court participants should be
“expected rather than considered an exception.”30 Finally, this Part
highlights the need for specialty court judges, staff, and policymakers
to become better educated about advances in the research and
treatment of co-occurring disorders because our greater
understanding of co-occurring disorders “will be useful only if there is
a treatment system in place to implement these findings.”31
I. ABOUT A REVOLUTION: SPECIALTY COURTS AND THE CRIMINAL
JUSTICE SYSTEM
The Miami-Dade Drug Court sparked a national revolution that
has forever changed our justice system.32

30. Kenneth Minkoff, Developing Standards of Care for Individuals with CoOccurring Psychiatric and Substance Use Disorders, 52 PSYCHIATRIC SERVS. 597, 597
(2001).
31. Brady & Sinha, supra note 16, at 1490 (“[C]hange at public policy levels will be
necessary to maximize the benefits derived from the findings of neurobiological
explorations in order to improve the lives of individuals with comorbidity.”).
32. History, NAT’L CTR. FOR DWI CTS., https://www.dwicourts.org/uncategorized/
drug-court-history/ [https://perma.cc/9U7N-JRC3].

97 N.C. L. REV. 355 (2019)

362

NORTH CAROLINA LAW REVIEW

[Vol. 97

The first drug court was established in Miami-Dade County,
Florida, in 1989.33 This special court was originally conceived as a way
to divert individuals with drug addiction out of the criminal justice
system and address the underlying addiction that led to the
individual’s arrest.34 Drug courts draw on therapeutic goals and seek
to provide addiction treatment to individuals whose involvement with
the criminal justice system is likely due to an underlying addiction.35
Drug courts offer criminal defendants with substance use disorders
the option of receiving court-monitored treatment, where the court
itself directs and guides the treatment process.36 In addition to these
therapeutic goals, however, drug courts also evolved as a more
practical response to the huge number of criminal cases on court
calendars, where many defendants with substance use disorders
“swamped the unprepared criminal justice system.”37
Drug and other specialty courts have been widely praised as
“revolutionary” and “innovative.”38 Indeed, “[t]he idea that the drug
court is an innovative form of justice is repeated like a mantra by its
supporters.”39 Moreover, as one Louisville drug court judge observed,
33. KING & PASQUARELLA, supra note 23, at 1; see also NOLAN, supra note 27, at 5
(“The burgeoning drug court movement first developed in response to the growing
number of drug cases overcrowding America’s criminal court calendars.”).
34. STRONG ET AL., supra note 26, at 1.
35. KING & PASQUARELLA, supra note 23, at 1; see also Michelle Edgely, Why Do
Mental Health Courts Work? A Confluence of Treatment, Support & Adroit Judicial
Supervision, 37 INT’L J.L. & PSYCHIATRY 572, 572 (2014) (describing mental health
courts, which grew out of the original drug court model, as “us[ing] a therapeutic
jurisprudence orientation to seek to reduce recidivism”); Michael L. Perlin, “The Judge,
He Cast His Robe Aside”: Mental Health Courts, Dignity and Due Process, 3 MENTAL
HEALTH L. & POL’Y J. 1, 2–3 (2013) (describing mental health courts as “significant
because of their articulated focus on dignity, as well as their embrace of therapeutic
jurisprudence, their focus on procedural justice, and their use of the principles of
restorative justice”).
36. NOLAN, supra note 27, at 39–40.
37. JANINE M. ZWEIG ET AL., URBAN INST. JUSTICE POLICY CTR., 2 THE MULTISITE ADULT DRUG COURT EVALUATION 7 (Shelli B Rossman et al. eds., 2011) (citing
various studies). The report details a number of reasons for the increase in criminal drug
charges, including “drug use prevalence, the crack cocaine epidemic of the 1980s, and
changes in legislation and criminal codes.” Id. These factors resulted in a “nearly threefold increase in drug and drug-related arrests” during the last quarter of the twentieth
century. Id.; see also Peggy Fulton Hora, William G. Schma & John T.A. Rosenthal,
Therapeutic Jurisprudence and the Drug Treatment Court Movement: Revolutionizing the
Criminal Justice System’s Response to Drug Abuse and Crime in America, 74 NOTRE
DAME L. REV. 439, 449 (1999) (noting that the focus of the first drug courts was “aimed
squarely at preventing the collapse of local court systems under the weight of drug cases”).
38. NOLAN, supra note 27, at 5 (“Judges celebrate the drug court as an exciting
movement, a new way of justice, even a revolution in American jurisprudence.”).
39. Eric J. Miller, Embracing Addiction: Drug Courts and the False Promise of
Judicial Interventionism, 65 OHIO ST. L.J. 1479, 1503 n.137 (2004); see also Hora et al.,
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the drug court model is “totally a grassroots kind of thing.”40 These
courts typically developed as a way to address a jurisdiction’s
particular needs at a local level.41 The courts are often created by
individual judges who then work to gain public support, gathering at
national conferences to “strategize about the ways they can get
outsiders to accept and support the drug court program.”42 This is not
entirely surprising, given that judges are on the ground—witnesses to
the institutional realities of enormous criminal calendars,
overcrowded prisons, and huge recidivism rates—and need to come
up with some other method for dealing with the large number of
criminal defendants charged with drug crimes.43 As one author put it,
“[t]he first [drug] courts were the product of local innovation and
‘elbow grease[]’ . . . .”44
While the praise has not been unanimous,45 the drug court model
has proved popular and received generally positive news coverage
and public support.46 Inspired by the success of the original drug court
model, judges began creating other specialty courts, including mental
health courts, family courts, youth specialty courts, DWI courts,
domestic violence courts, veterans courts, tribal wellness courts, and
supra note 37, at 440 (describing the “existence, breadth, and importance of the [drug
court] movement in this country”).
40. NOLAN, supra note 27, at 42 (quoting Louisville Drug Court Judge Henry Weber,
who notes that while drug courts do receive federal dollars, the movement itself is “not
something where the bureaucrats in Washington tell you what to do”).
41. Id.
42. Id. at 42–43 (“The Drug Court movement is essentially a judge-led movement.”);
see also MITCHELL B. MACKINEM & PAUL HIGGINS, DRUG COURT: CONSTRUCTING THE
MORAL IDENTITY OF DRUG OFFENDERS 61 (2008) (“[J]udges often lead the effort for
the establishment of drug court.”).
43. NOLAN, supra note 27, at 44 (noting that “the criminal justice system was faced
with a situation where something new had to be tried” and citing a common refrain from
drug court officials that “what we were doing before simply was not working”).
44. John S. Goldkamp, The Drug Court Response: Issues and Implications for Justice
Change, 63 ALB. L. REV. 923, 948 (2000).
45. For an excellent overview of some of the common objections to the drug court
model, see generally JUSTICE POLICY INST., supra note 24; Sara Gordon, The Use and
Abuse of Mutual-Support Programs in Drug Courts, 2017 ILL. L. REV. 1503, 1541 (2017)
(“Even when individuals are required by courts to receive treatment, much of the
treatment they receive is not evidence-based and is not delivered in licensed facilities by
qualified providers.”); Morris B. Hoffman, The Drug Court Scandal, 78 N.C. L. REV. 1437,
1477 (2000) (“By simultaneously treating drug use as a crime and as a disease, without
coming to grips with the inherent contradictions of those two approaches, drug courts are
not satisfying either the legitimate and compassionate interests of the treatment
community or the legitimate and rational interests of the law enforcement community.”).
46. NOLAN, supra note 27, at 5 (noting that problem-solving courts received “almost
uniformly positive media coverage and overwhelming public support at both the national
and local levels”).

97 N.C. L. REV. 355 (2019)

364

NORTH CAROLINA LAW REVIEW

[Vol. 97

many others.47 The Bureau of Justice Statistics’s most recent census of
specialty courts counted 3052 specialty courts in the United States.48
Other researchers suggest the number of drug and other specialty
courts is even higher, estimating that there are over 2400 drug
treatment courts and more than 1000 additional specialty courts in the
United States, the majority of which use the same drug court model.49
47. Edgely, supra note 35, at 572; see also JUSTICE POLICY INST., supra note 24, at 18–
20; STRONG ET AL., supra note 26, at 1. Other specialty courts include gambling court,
prostitution court, campus court, and many others. JUSTICE POLICY INST., supra note 24,
at 18–20.
Due to the popularity of drug courts, many states and localities have expanded on
this model to address other social issues experienced by people involved in the
justice system. . . . Here are some of the current specialty courts in place around
the country[:]
Tribal Healing and Wellness Court
A component of the tribal justice system, the Tribal Healing and Wellness
Courts were created to address alcohol and drug misuse in tribal
communities. It is based on the traditional drug court model, but is tailored to
the unique needs of the tribal community and incorporate[s] culture and
tradition. . . .
Reentry Court
Started in 2000 by the Office of Justice Programs’ Reentry Court Initiative,
reentry drug courts were created to aid the unique process of moving from
prison into the community. . . .
Juvenile Drugs Court
The juvenile drug court is a special docket within a juvenile court that is
assigned to a designated judge and involves intensive treatment and
supervision services for youth with delinquency or status offenses who are
considered drug-involved. . . .
Community Court
The community courts deal with quality of life crimes within a community,
such as prostitution, vandalism, or petty theft. . . .
Gambling Court
Gambling court operates through existing drug courts, selecting specific cases
involving people who have a pending criminal charge and suffer from
pathological or compulsive gambling disorders that may have resulted in
illegal activity. . . .
Truancy Court
Truancy courts are designed to identify and assist with the underlying causes
of truancy occurring in a child’s life. . . .
Id. at 18–19.
48. STRONG ET AL., supra note 26, at 1.
49. HUDDLESTON & MARLOWE, supra note 25, at 1. According to this report, as of
December 31, 2009, there were a total of 3648 drug courts and other specialty courts. Id.
Of these, approximately 2459 were drug courts and the remainder were other specialty
courts. Id.
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One recent study found that more than 55,000 people enter drug
court each year and “about 515 million dollars is spent annually to
treat those drug court clients.”50
In the early days of drug courts, messaging was key, as was the
need for funding. In 1994, a group of “pioneers” from twelve early
drug courts formed the National Association of Drug Court
Professionals (“NADCP”), a nonprofit group tasked with creating “a
common-sense approach to improving the justice system by using a
combination of judicial monitoring and effective treatment to compel
drug-using offenders to change their lives.”51 The NADCP is
committed to persuading legislators, local judges, and the general
public of these “guiding principles” through legislative lobbying, press
conferences, and an “ongoing media blitz that landed Drug Courts
and the NADCP on all major television networks and in Newsweek,
USA Today, The Washington Post, The New York Times, and
countless other newspapers.”52 The NADCP has also worked to
improve the public’s perception of drug and specialty courts and
recently launched “All Rise,” a public awareness campaign starring
celebrities, including Matthew Perry, Martin Sheen, and Trey
Anastasio.53
According to the NADCP, these efforts have resulted in
“historical” and “staggering” increases in federal funding for specialty

50. AVINASH SINGH BHATI, JOHN K. ROMAN & AARON CHALFIN, URBAN INST.
JUSTICE POLICY CTR., TO TREAT OR NOT TO TREAT: EVIDENCE ON THE PROSPECTS OF
EXPANDING TREATMENT TO DRUG-INVOLVED OFFENDERS xi–xii (2008),
https://www.urban.org/sites/default/files/publication/31621/411645-To-Treat-or-Not-to-Treat.
PDF [https://perma.cc/6DGH-7865]; see also NOLAN, supra note 27, at 43 (noting that the
drug court model has spread to other countries, including Canada, Australia, and
England).
51. About NADCP, NAT’L CTR. FOR DWI CTS., https://www.dwicourts.org/
uncategorized/about-nadcp/ [https://perma.cc/39KR-KLGV].
52. Id. (“In 2006, NADCP launched a massive campaign to put a Drug Court within
reach of every American in need. NADCP has aggressively pursued its vision and
achieved a renewed commitment for Drug Courts among Congress and the general public
alike.”).
53. Nick Gillie & West Huddleston, “All Rise!”: A Better Way of Justice Is Now in
Session, HUFFPOST (Aug. 21, 2009, 5:12 AM), https://www.huffingtonpost.com/nickgillie/all-rise-a-better-way-of_b_242101.html [http://perma.cc/84WH-SDTM]; see also All
Rise, Martin Sheen: All Rise!, YOUTUBE (Nov. 29, 2011), https://www.youtube.com/
watch?v=YjVQB4EvytI [http://perma.cc/AQ5Z-544L]; All Rise, Matthew Perry Accepts
the All Rise Ambassador Award for His Dedication to Drug Court Advocacy, YOUTUBE
(Aug. 3, 2011), https://www.youtube.com/watch?reload=9&v=1SJSblulFqA [http://perma.cc/
242E-XJ8R]; Trey Anastasio Given Award by National Association of Drug Court
Professionals, HEADCOUNT (Jul. 22, 2011), https://www.headcount.org/trey-anastasio-givenaward-by-national-association-of-drug-court-professionals/ [http://perma.cc/9CP2-PL3A].
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courts.54 Whether due to the promotional work of the NADCP or to
other factors, it is the case that drug and other specialty courts receive
significant financial support from both the federal government and
from state and local entities.55 In 1995, the U.S. Department of Justice
opened the Drug Courts Program Office, which awards grants to
existing and emerging drug courts.56 Today, however, the majority of
specialty courts are funded by state grants or through the state
budget. In 2012, for example, 60% of courts received some funding
from the state, 23% were funded entirely by the state, and 20%
received up to half of their funding from court fees or fines.57
In addition to support from individual states, federal funding for
specialty courts has remained robust, in part due to the increasing
recognition of a nationwide opioid epidemic.58 In July 2017, for
example, the U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
(“SAMHSA”) announced grant funding of up to $80.8 million for
adult drug courts.59 And in September 2017, Attorney General Jeff
Sessions announced that the Department of Justice would award
about $24 million in federal grants to assist state and local
governments in creating “comprehensive diversion and alternatives to
incarceration programs for those impacted by the opioid epidemic.”60
In addition to its fundraising initiatives, the NADCP also
considers itself responsible for much of the training received by
specialty court judges and court personnel. As part of these training
54. About NADCP, supra note 51.
55. NOLAN, supra note 27, at 42 (“It’s probably the only movement in the judicial
system that has bubbled up from the grassroots to the Federal government.”).
56. Id. at 41–42 (“In fiscal year 1995 the office granted $12 million in grants to drug
courts. This increased to $15 million in 1996, to $30 million in both 1997 and 1998, and
then to $40 million in 1999.”).
57. STRONG ET AL., supra note 26, at 12.
58. See, e.g., Maya Salam, The Opioid Epidemic: A Crisis Years in the Making, N.Y.
TIMES (Oct. 26, 2017), https://www.nytimes.com/2017/10/26/us/opioid-crisis-public-healthemergency.html [https://perma.cc/S268-RE7A (dark-archive)].
59. Announces $80.8 Million in Grants for Adult and Family Treatment Drug Courts,
and Adult Tribal Healing to Wellness Courts, U.S. DEP’T HEALTH & HUM. SERVS. (July
14, 2017), https://www.hhs.gov/about/news/2017/07/14/hhs-announces-808-million-grantsadult-and-family-treatment-drug-courts-and-adult-tribal-healing.html [https://perma.cc/FW28BARJ] (“The actual award amounts may vary, depending on the availability of funds.”).
However, “[f]ewer than a quarter (23%) of these courts operating in 2012 reported that
they received some federal grants to support their programs.” STRONG ET AL., supra note
26, at 12.
60. Department of Justice Awards Nearly $59 Million to Combat Opioid Epidemic,
Fund Drug Courts, U.S. DEP’T JUST. (Sept. 22, 2017), https://www.justice.gov/opa/
pr/department-justice-awards-nearly-59-million-combat-opioid-epidemic-fund-drug-courts
[https://perma.cc/4WUS-WYVL].
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efforts, the NADCP created the National Drug Court Institute, “the
definitive authority on the latest research, best practices, and cuttingedge innovations to treat offenders facing substance use and mental
health disorders.”61 According to its website, the NADCP has trained
over 36,000 drug court judges and court personnel and distributes its
educational materials to drug courts nationally and internationally.62
The NADCP also hosts an annual conference on specialty courts and
criminal justice reform and drew more than 6000 drug court
personnel to its 2018 conference in Houston, Texas.63
The NADCP does recognize that large numbers of individuals
who enter a drug, alcohol, or mental health court meet diagnostic
criteria for both a substance use and mental health disorder. In 2011,
it issued a resolution from its Board of Directors concluding that the
NADCP will “actively collaborate with other organizations to
advocate expansion of Drug Courts and Mental Health Courts which
also effectively meet the needs of those participants with co-occurring
disorders.”64 Notwithstanding this recognition, however, and perhaps
in part due to its history of individual judges tackling local problems,
the vast majority of specialty courts are still targeted toward small
segments of the population, accepting individuals into segregated
gambling courts, homeless courts, or veterans courts.65 In particular,
the majority of individuals who enter a specialty court are referred
into either drug, alcohol, or mental health court.66
The original drug court model served as a basis for the
development of alcohol and DWI courts, as well as mental health
courts.67 But, unlike drug courts, which focus on drug-related charges
and often have a more punitive focus,68 mental health courts are often
61. About NDCI, NAT’L DRUG CT. INST., https://www.ndci.org/about-ndci/
[https://perma.cc/4Q7Q-7JLK].
62. About NADCP, supra note 51 (noting that it has “developed 37 publications,
disseminating them to 456,166 professionals worldwide”).
63. Chris Deutsch, Conference May Be Over but the Mission Continues, NAT’L ASS’N
DRUG CT. PROFS., http://www.nadcp.org/nadcp-conference/conference-may-be-over-butthe-mission-continues/ [https://perma.cc/GRS2-VAY7].
64. NAT’L ASS’N OF DRUG COURT PROF’LS, RESOLUTION OF THE BOARD OF
DIRECTORS ON IMPROVING OUTCOMES FOR JUSTICE INVOLVED PERSONS WITH
MENTAL ILLNESSES INCLUDING THOSE WITH CO-OCCURRING SUBSTANCE ABUSE
DISORDERS 3 (2011), http://ndcrc.org/resource/improving-outocmes-for-justice-involvedpersons-with-mental-illnesses-including-those-with-co-occurring-substance-abuse-disorders/
[https://perma.cc/QUB4-2RPD].
65. See supra Part I.
66. See infra Part V.
67. See JUSTICE POLICY INST., supra note 24, at 18; Edgely, supra note 35, at 572.
68. U.S. DEP’T OF JUSTICE, supra note 28, at 9; Griffin et al., supra note 28, at 1288;
see also Philip Bean, America’s Drug Courts: A New Development in Criminal Justice, 1996
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described as treatment courts and have the stated goal of connecting
participants to available community resources.69 As one author noted,
“punishment is considered a core feature of drug courts and is used
routinely in that setting,” while there is more reluctance to impose
punishment “if the perceived cause of the criminal behavior is mental
illness.”70 Mental health courts, therefore, have a different focus than
drug courts, and have been described as “not merely drug courts for
people with mental illnesses.”71
When individuals are arrested for a drug-related charge, they are
often diverted into a drug court.72 In contrast, mental health courts
admit defendants charged with a variety of offenses.73 Significantly,
drug courts and mental health courts are often distinguished from one
another due to the fact that “mental illness, unlike drug use, is, in and
of itself, not a crime . . . .”74 Moreover, unlike drug courts, which
typically limit participants to nonviolent drug crimes,75 many mental
health courts are willing to accept participants who are charged with
more serious felony offenses or violent crimes, in part because the
longer sentences available for participants charged with felonies allow
the court to coordinate and supervise community-based treatment for
longer periods of time.76
CRIM. L. REV. 718, 719 (“[T]he control exercised by Drug Courts means offenders can no
longer manipulate the system as they have done hitherto. With up-to-date urinalysis, and
daily reports from treatment providers, control is firm and obvious.”).
69. ALMQUIST & DODD, supra note 29, at 2 (describing a variety of goals for mental
health courts, including goals “to improve public safety by reducing the recidivism rates of
people with mental illnesses, to reduce corrections costs by providing alternatives to
incarceration, and to improve the quality of life of people with mental illnesses by
connecting them with treatment and preventing re-involvement in the criminal justice
system”).
70. Griffin et al., supra note 28, at 1288.
71. U.S. DEP’T OF JUSTICE, supra note 28, at 9; John Petrila et al., Preliminary
Observations from an Evaluation of the Broward County Mental Health Court, CT. REV.,
Winter 2001, at 14, 20 (noting that the difference between drug courts and mental health
courts “is a fundamental one”).
72. Similarly, individuals arrested for an alcohol-related offense, like a DWI charge,
are referred to an alcohol or DWI court, where the focus is “on changing the behavior of
the alcohol-dependent offender . . . .” STRONG ET AL., supra note 26, at 2; see also infra
text accompanying note 209.
73. U.S. DEP’T OF JUSTICE, supra note 28, at 9.
74. Id.
75. Few drug courts will accept a defendant who is charged with a violent crime,
including felony domestic violence (20.1%) or misdemeanor violence (16.3%). ZWEIG ET
AL., supra note 37, at 25–26, 26 tbl.2-2.5. Many courts explicitly exclude individuals
charged with crimes against other people or against children. See id.
76. ALMQUIST & DODD, supra note 29, at 9 (“[S]ome jurisdictions decided to focus
on people with felony charges to allow court professionals to engage participants in
community-based treatment for longer periods of time, which was perceived as necessary
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Yet high rates of co-occurring mental illness and substance use
disorders “also suggests significant overlap in the target populations
of these related court programs.”77 In fact, some jurisdictions initially
established mental health courts because existing drug courts did not
have the resources to manage participants with serious mental
illnesses.78 Additionally, numerous studies have confirmed that rates
of co-occurring disorders among mental health court participants are
similar to those seen among the general population.79 For example,
83% of participants in a Santa Barbara, California, mental health
court had a co-occurring substance use diagnosis, while 59% of
participants in the Anchorage, Alaska, mental health court and 56%
of participants in the San Francisco, California, mental health court
had a similar diagnosis.80
This piecemeal approach where individuals with drug or alcohol
related charges are assigned to drug court and other individuals are
assigned to mental health court is contrary to the literature on cooccurring disorders, which indicates that co-occurring mental health
and substance use disorders occur so frequently that they “should be
expected rather than considered an exception.”81 If specialty courts
are to continue providing “cutting-edge innovations to treat offenders
facing substance use and mental health disorders,”82 the structure of
the specialty court system should itself be changed to provide
comprehensive and integrated treatment to participants. Unless
specialty courts are restructured to eliminate the artificial barriers
between drug, alcohol, and mental health courts, it seems unlikely
that individual courts will be able to adequately address the huge

to produce positive outcomes. The longer stays for individuals charged with serious crimes
was not longer than the prison sentences they would have faced if convicted.”). But see E.
Lea Johnston & Conor P. Flynn, Mental Health Courts and Sentencing Disparities, 62
VILL. L. REV. 685, 693 (2017) (finding that mental health court sentences in an Erie
County, Pennsylvania, court “typically exceed county court sentences by more than a
year”); Ira Glass, Very Tough Love, THIS AM. LIFE (Mar. 25, 2011),
http://www.thisamericanlife.org/radio-archives/episode/430/very-tough-loveo [https://perma.cc/
Z5JX-D3DH] (describing the story of Lindsey Dills, a seventeen-year-old girl who forged
two checks from her parents’ bank account, “one for $40 and one for $60,” and was a
participant in drug court for almost six years. This time period included “14 months
behind bars, and then . . . another five years after that—six months of it in Arrendale State
Prison, the other four and a half on probation”).
77. U.S. DEP’T OF JUSTICE, supra note 28, at 9.
78. Id.
79. See infra Part III.
80. ALMQUIST & DODD, supra note 29, at 10.
81. Minkoff, supra note 30, at 597.
82. About NDCI, supra note 61.
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number of individuals with co-occurring disorders who are diverted
out of the criminal justice system and into specialty courts.
Moreover, and as discussed in the next part, substance use
disorder is a brain disease, which is recognized and diagnosed like any
other mental illness. The segregation of drug, alcohol, and mental
health courts is yet another barrier to the widespread acceptance of
addiction as a disease, one that should be evaluated and treated like
any other mental health disorder, and not relegated to the fringes of
mainstream medicine.
II. SUBSTANCE USE DISORDER: A MENTAL ILLNESS ON THE
FRINGES
Substance use disorder—or addiction83—is a complex brain
disease that affects multiple parts of the brain, “including those
involved in reward and motivation, learning and memory, and
inhibitory control over behavior.”84 The disease of addiction affects
nearly 16% of Americans over the age of twelve—over forty million
people—more than the number of people with heart disease,
diabetes, or cancer.85 An additional 31.7%, or 80.4 million people,
“engages in risky use of addictive substances in ways that threaten
[their] health and safety,” or the safety of others.86 Addiction is also a
chronic disorder, one that requires ongoing treatment and
management.87
83. Although the DSM-5 has eliminated the word “addiction,” many clinicians and
researchers continue to use the term, and this Article will use both “addiction” and
“substance use disorder” to encompass “substance use disorder” as it is defined in the
DSM-5. AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL
DISORDERS 483 (5th ed. 2013) [hereinafter DSM-5].
84. Nora D. Volkow, Preface to the Third Edition of NAT’L INST. ON DRUG ABUSE,
PRINCIPLES OF DRUG ADDICTION TREATMENT: A RESEARCH BASED GUIDE 3, 3 (3d ed.
2018), https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/675-principles-of-drug-addictiontreatment-a-research-based-guide-third-edition.pdf [https://perma.cc/44T4-5QEY]; Charles
Dackis & Charles O’Brien, Neurobiology of Addiction: Treatment and Public Policy
Ramifications, 8 NATURE NEUROSCIENCE 1431, 1431 (2005) (noting that, in the United
States, the “public . . . views addiction more as a social problem than an actual disease,
despite scientific evidence supporting a disease concept of addiction based on neuronal
mechanisms, heritability, treatment responses and a characteristic progressive clinical
course”).
85. Drew E. Altman, Preface to NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE
AT COLUMBIA UNIV., ADDICTION MEDICINE, CLOSING THE GAP BETWEEN SCIENCE
AND PRACTICE, at i, i (2012) https://www.centeronaddiction.org/download/file/fid/1177
[https://perma.cc/R5Z5-4E4H] (“Addiction affects 16 percent of Americans ages 12 and
older—40 million people. That is more than the number of people with heart disease (27
million), diabetes (26 million) or cancer (19 million).”).
86. Id. at 1.
87. Id. at 7.
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The field of addiction research has grown significantly over the
last several decades, beginning with animal models and expanding to
include neuroimaging studies of the brains of individuals with
addiction.88 The literature on addiction has consistently demonstrated
a biological basis for the disease and has established that addiction is
a disease that affects the reward centers of the brain.89 In turn, these
reward centers affect motivation and have evolved to control human
behavior that is directed toward survival goals, even in the presence
of danger.90 Addictive substances “essentially hijack brain circuits that
exert considerable dominance over rational thought, leading to
progressive loss of control over drug intake in the face of medical,
interpersonal, occupational and legal hazards.”91 The continued use of
addictive substances can physically alter the structure and functioning
of the brain and result in changes to the brain that remain even after
the individual has stopped taking the drug.92 Moreover, the disease
has significant behavioral characteristics; addiction to a substance can
cause the individual to engage in behavior even when that behavior
results in unfavorable consequences.93
There is some debate in the addiction literature about how to
appropriately characterize the disease of addiction, and “the
discourse around addiction remains contentious and complex.”94
88. Dackis & O’Brien, supra note 84, at 1431 (“Much of our knowledge about
addiction neurobiology is based on decades of animal studies that model the dynamic
clinical components of the illness.”).
89. Id.
90. Id. (“Given their function, reward centers have evolved the ability to grip
attention, dominate motivation and compel behavior directed toward survival goals, even
in the presence of danger and despite our belief that we are generally rational beings.”).
91. Id.; see also Alan I. Leshner, Addiction Is a Brain Disease, ISSUES SCI. & TECH.,
Spring 2001, at 75, 75 [hereinafter Leshner, A Brain Disease] (“It is as if drugs have
highjacked the brain’s natural motivational control circuits, resulting in drug use becoming
the sole, or at least the top, motivational priority for the individual.”).
92. NAT’L INST. ON DRUG ABUSE, supra note 84, at 5; see also DSM-5, supra note 83,
at 483 (“An important characteristic of substance use disorders is an underlying change in
brain circuits that may persist beyond detoxification, particularly in individuals with severe
disorders.”); Alan I. Leshner, Addiction Is a Brain Disease, and It Matters, 278 SCIENCE
45, 46 (1997) (“Significant effects of chronic use have been identified for many drugs at all
levels: molecular, cellular, structural, and functional. The addicted brain is distinctly
different from the non-addicted brain, as manifested by changes in brain metabolic
activity, receptor availability, gene expression, and responsiveness to environmental
cues.”).
93. NAT’L INST. ON DRUG ABUSE, supra note 84, at 3.
94. Rachel Hammer et al., Addiction: Current Criticism of the Brain Disease
Paradigm, 4 AM. J. BIOETHICS NEUROSCIENCE 27, 28 (2013); see also Daniel Z.
Buchman, Wayne Skinner & Judy Illes, Negotiating the Relationship Between Addiction,
Ethics, and Brain Science, AM. J. BIOETHICS NEUROSCIENCE 36, 42 (2010) (“Neuroethics
challenges arise when knowledge exclusively from neuroscience is deemed adequate to
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Some researchers believe that the current emphasis on a brain-disease
model is a well-intentioned attempt to “debunk[] the moralized
argument that addiction is a problem for weak-willed people.”95
These commentators suggest a biological understanding of addiction,
one that uses biology to explain a condition with social ramifications.
Viewed in this light, addiction is “a chronic, relapsing,
biopsychosocial disorder that cannot be understood apart from social
context” and not simply a brain disease.96
Further complicating the conversation about addiction as a
disease is the fact that it is a disease that begins when an individual
voluntarily engages in substance use, and many “erroneously still
believe that drug addiction is simply a failure of will or of strength of
character.”97 And even if we accept that addiction is a disease of the
brain, it is still the case that the addicted individual has a significant
role to play both in her illness and her recovery. Yet, while it is true
that “having this brain disease does not absolve the addict of
responsibility for his or her behavior, . . . it does explain why an addict
cannot simply stop using drugs by sheer force of will alone.”98 The
literature on addiction also overwhelmingly supports the need for a
“much more sophisticated approach to dealing with the array of
problems surrounding drug abuse and addiction in our society.”99
Even in the face of this ongoing debate about the definition of
addiction, however, “the majority of the biomedical community now
considers addiction, in its essence, to be a brain disease: a condition
caused by persistent changes in brain structure and function.”100 And
whether we characterize addiction as a brain disease, a
obtain a full understanding of a mental health disorder as complex as addiction. While the
practicality of a biopsychosocial systems model may allow for a more integrative
explanation for addiction, it does not explain addiction entirely.”).
95. Hammer et al., supra note 94, at 28. This article describes the concept of
“othering” as a way in which human groups react to other “groups of people who exhibit
unfavorable behavior or characteristics against the backdrop of cultural norms” and
argues that “[t]hose who believe that diseasing addiction will reduce stigma fail to
recognize how disease itself has its own stigma; the diseased are often just as set apart as
‘wretches’ and ‘sinners.’” Id. at 30.
96. Id. at 31 (“We are embodied beings. Biologically, that addiction rests on a
neurochemical platform is evident and potentially useful. However, it is not necessary to
frame addiction as a disease to access the benefits from biological addiction research.”);
see also Buchman et al., supra note 94, at 37 (advocating “a biopsychosocial systems model
of, and approach to, addiction, in which psychological and sociological factors complement
and are in a dynamic interplay with neurobiological and genetic factors”).
97. Leshner, A Brain Disease, supra note 91, at 76.
98. Id.
99. Id.
100. Id. at 75.
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biopsychosocial disorder, or “somewhere in a middle ground,”101
clinicians diagnose addiction using behavioral components. This
diagnosis—like all other mental health diagnoses—is made using the
Diagnostic and Statistical Manual, or DSM-5.102
According to the DSM-5 diagnostic criteria, individuals can be
diagnosed with a “substance use disorder” on a continuum from mild
to severe.103 Unlike older versions of the DSM, the most recent
edition does not distinguish among substances, and almost all
substances are diagnosed using the same set of behavioral criteria.104
Significantly, the DSM-5 does not use the word “addiction”; although
the word “addiction” is often used to describe “severe problems
related to compulsive and habitual use of substances,” the DSM-5
uses the “more neutral term substance use disorder . . . to describe the
wide range of the disorder, from a mild form to a severe state of
chronically relapsing, compulsive drug taking.”105
Perhaps mindful of the historical stigma associated with
substance use, the authors of the DSM-5 chose to eliminate the word
“addiction” “because of its uncertain definition and its potentially
negative connotation.”106 Similarly, and despite its longstanding
inclusion in the DSM, substance use disorder and its treatment have
101. Hammer et al., supra note 94, at 27. As one author frankly notes,
The United States is stuck in its drug abuse metaphors and in polarized arguments
about them. Everyone has an opinion. . . . People see addiction as either a disease
or as a failure of will. None of this bumper sticker analysis moves us forward. The
truth is that we will make progress in dealing with drug issues only when our
national discourse and our strategies are as complex and comprehensive as the
problem itself.
Leshner, A Brain Disease, supra note 91, at 75.
102. See DSM-5, supra note 83, at 483. The DSM is used by clinicians to identify and
diagnose mental illness. The new version eliminated the separate diagnoses of substance
“dependence” and “abuse” and replaced them with a single diagnosis of substance use
disorder. AM. PSYCHIATRIC ASS’N, SUBSTANCE-RELATED AND ADDICTION DISORDERS
1 (2013) [hereinafter SUBSTANCE-RELATED AND ADDICTION DISORDERS],
https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM-5Substance-Use-Disorder.pdf [https://perma.cc/8GYK-R7WA].
103. DSM-5, supra note 83, at 484 (“Substance use disorders occur in a broad range of
severity, from mild to severe, with severity based on the number of symptom criteria
endorsed.”).
104. As the DSM-5 notes, “the diagnosis of a substance use disorder can be applied to
all 10 classes included in this chapter except caffeine. For certain classes some symptoms
are less salient, and in a few instances not all symptoms apply.” Id. at 483. The ten classes
of addictive substances referenced in the DSM-5 include alcohol, caffeine, cannabis,
hallucinogens, inhalants, opioids, sedatives, stimulants, and tobacco, among others. Id. at
482.
105. Id. at 485.
106. Id.
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been historically marginalized “as a social problem rather than
[treated] as a medical condition.”107 In fact, few people who engage in
either risky use or abuse of substances receive adequate, ongoing,
evidence-based treatment.108
Like treatment for other chronic diseases, “best practices for the
effective treatment and management of addiction must be consistent
with the scientific evidence of the causes and course of the disease.”109
Evidence-based
addiction
treatment
requires
an
initial
comprehensive assessment of the patient, including a thorough
history, physical exam, and psychosocial evaluation.110 Next, and
before treatment begins, patients should be stabilized and receive
medical management of withdrawal, or detoxification, if necessary.111
The patient should then receive acute treatment, which should be
provided by qualified health care professionals and should include
treatment for any co-occurring physical or mental health conditions.112
Next, the individual should receive chronic disease management to
assist with maintenance of the progress achieved during treatment
and to help prevent relapse.113 Finally, the patient should receive
support services, which include wraparound services in the
community, like legal, educational, employment, and housing
support, and community-based mutual support programs.114
Despite our growing understanding of effective treatment for
addiction, few people with a substance use disorder receive
appropriate and ongoing evidence-based treatment.115 Unlike
treatment for other mental health conditions, which is based on best
107. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 4 (“This profound gap between the science of addiction and current practice
related to prevention and treatment is a result of decades of marginalizing addiction as a
social problem rather than treating it as a medical condition.”).
108. Id. at 131.
109. Id. at 9; see also AM. SOC’Y OF ADDICTION MED., PUBLIC POLICY STATEMENT ON
TREATMENT FOR ALCOHOL AND OTHER DRUG ADDICTION 2 (2010),
https://www.asam.org/docs/default-source/public-policy-statements/1treatment-4-aod-1-10.
pdf?sfvrsn=4d7d8b19_0 [https://perma.cc/Y3EA-9SK4].
110. AM. SOC’Y OF ADDICTION MED., supra note 109, at 2; see also NAT’L CTR. ON
ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra note 85, at 9.
111. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2.
112. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2.
113. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2.
114. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 9; see also AM. SOC’Y OF ADDICTION MED., supra note 109, at 2.
115. See infra Part IV.
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practices and administered by highly trained medical professionals,
the disease of addiction is often treated on the fringes of mainstream
medicine. The treatment is provided in mutual support programs by
individuals with little or no medical training and is rarely supervised
by trained medical professionals.116 Physicians, nurses, and other
trained medical professionals are typically consulted only when
necessary.117 Often, individuals who seek out or are ordered into
treatment receive “brief, episodic interventions,” which might be part
of the explanation for high rates of relapse among substance
abusers.118
Some researchers suggest that this disconnect between
mainstream medicine and substance use treatment is due to the
societal stigma of addiction, and that this stigma “contribute[s] to
policies that would be simply unacceptable if applied to ‘real’ medical
disorders.”119 Individuals with addiction are often treated not as
patients but are instead blamed or criminalized for their behavior.120
In turn, these attitudes are embraced by “[a]n uneducated yet
strongly opinionated public [that] does not understand the technical
field of addiction neurobiology and is more likely to conceptualize
addiction as a character flaw . . . than a brain disease.”121
Instead of receiving evidence-based treatment for their illness,
many individuals with a substance use disorder therefore go
untreated, and for some, their first exposure to treatment can come as
a result of diversion into a drug, alcohol, or mental health court. By
segregating specialty courts in this way, however, we are further
stigmatizing addiction and failing to acknowledge that drug and
alcohol use disorders are one of the many types of mental illnesses
recognized by the DSM-5.122 Furthermore, individuals who are
diverted into drug or alcohol court often receive one type of
116. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 212.
117. Id. (“Physicians and other medical professionals typically are absent from or on
the periphery of the treatment process, occasionally being called in to provide a
prescription or medically monitor a detoxification protocol.”).
118. Id. at 7.
119. Dackis & O’Brien, supra note 84, at 1431 (“Stigma and misconception create
formidable obstacles to a more enlightened public policy toward addictive illness.”).
120. Id.
121. Id.
122. For a comprehensive discussion of the stigmatizing effects of the specialty court
model, see generally Lea Johnson, Theorizing Mental Health Courts, 89 WASH. U. L. REV.
519, 540–43 (2012) (noting that mental health courts contribute to “impressions about
offenders with mental illnesses that act synergistically to deepen and reinforce the stigma
and isolation associated with mental illness”).
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treatment—substance use treatment—much of which is not evidence
based and is not delivered in licensed facilities by qualified
providers.123 Moreover, as discussed in the next part, many of these
individuals are also likely to meet diagnostic criteria for an additional
mental health disorder, a diagnosis that may remain unidentified and
untreated in a traditional drug court.
III. PREVALENCE OF CO-OCCURRING MENTAL HEALTH AND
SUBSTANCE USE DISORDERS
Comorbidity is so common that dual diagnosis should be
expected rather than considered an exception.124
Although many individuals will have some combination of
mental health and substance use disorder at some point in their
lifetime,125 this Article focuses on individuals with a co-occurring
substance use disorder and serious mental illness. As described
above, substance use disorder refers to abuse or dependence on
alcohol or illicit drugs and “is used to describe the wide range of the
disorder, from a mild form to a severe state of chronically relapsing,
compulsive drug [or alcohol] taking.”126 “Serious mental illness”
refers to individuals with a mental, behavioral, or emotional disorder
that substantially interferes with or limits one or more major life
activities.127 Among individuals with a serious mental illness, “the
most common and clinically significant” type of co-occurring disorder
is substance use disorder.128 About 1%, or 2.3 million American
123. Gordon, supra note 45, at 1539–41.
124. Minkoff, supra note 30, at 597.
125. See H. Westley Clark et al., Policy and Practice Implications of Epidemiological
Surveys on Co-Occurring Mental and Substance Use Disorders, 34 J. SUBSTANCE ABUSE
TREATMENT 3, 4–5 (2008). See generally U.S. DEP’T OF HEALTH & HUM. SERVS., THE
EVIDENCE: INTEGRATED TREATMENT FOR CO-OCCURRING DISORDERS (2013)
[hereinafter INTEGRATED TREATMENT], https://store.samhsa.gov/system/files/theevidenceitc.pdf [https://perma.cc/QED4-GYZF] (discussing effective treatment options for cooccurring disorders).
126. DSM-5, supra note 83, at 485.
127. According to the U.S. Department of Health and Human Services, mental illness
“is the term that refers collectively to all diagnosable mental disorders. Mental disorders
are health conditions that are characterized by alterations in thinking, mood, or behavior
(or some combination thereof) associated with distress and/or impaired functioning.” U.S.
DEP’T. OF HEALTH & HUM. SERVS., MENTAL HEALTH: A REPORT OF THE SURGEON
GENERAL 5 (1999), https://profiles.nlm.nih.gov/ps/access/NNBBHS.pdf [https://perma.cc/
PG6C-SYYQ]. A serious mental illness is one that “interferes with some area of social
functioning.” Id. at 46.
128. Robert E. Drake et al., A Review of Treatments for People with Severe Mental
Illnesses and Co-Occurring Substance Use Disorders, 27 PSYCHIATRIC REHABILITATION
J. 360, 360 (2004) [hereinafter Drake et al., A Review of Treatments] (noting that while
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adults, had both a serious mental illness and a substance use disorder
in 2014.129
Among individuals with a serious mental illness, as many as 40%
have a co-occurring substance use disorder.130 Similarly, among
individuals with a substance use disorder, almost half have a cooccurring mental health disorder.131 Recent research into co-occurring
disorders supports a strong association between mental health
disorders and substance use disorders, but “the nature of the
relationship is complex.”132 For a small number of individuals, one
disorder can be caused by the other; for instance, long term substance
use can, in some cases, damage the brain and lead to chronic mental
health disorders.133 Some studies have also found that the use of
addictive substances like nicotine, alcohol, or marijuana actually
increase an individual’s risk for developing a mental health condition
like anxiety or depression.134 In other cases—particularly in
terms like “dual diagnosis” and “dual disorders” are often used in the literature, they are
“clearly misnomers, because the individuals with a co-occurring severe mental illness and
a substance use disorder typically have multiple impairments rather than only two illnesses
and because there are several other groups with dual diagnoses, such as people with
developmental disabilities and mental illnesses”).
129. SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., BEHAVIORAL
HEALTH TRENDS IN THE UNITED STATES: RESULTS FROM THE 2014 NATIONAL SURVEY
ON DRUG USE AND HEALTH 33 (2015), https://www.samhsa.gov/data/sites/default/files/
NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf [https://perma.cc/9YZH-9M5D] (noting
that 3.3%, or 7.9 million people, met diagnostic criteria for any mental illness and a
substance use disorder). But see Clark et al., supra note 125, at 5 (“[W]hen treating
substance use disorders that co-occur with mental illness, the illness can be either severe
or mild to moderate.”).
130. Katherine E. Watkins et al., A National Survey of Care for Persons with CoOccurring Mental and Substance Use Disorders, 52 PSYCHIATRIC SERVS. 1062, 1062
(2001) [hereinafter Watkins et al., A National Survey]; see also Ronald C. Kessler et al.,
The Epidemiology of Co-Occurring Addictive and Mental Disorders: Implications for
Prevention and Service Utilization, 66 AM. J. ORTHOPSYCHIATRY 17, 25 (1996) (noting in
a discussion of two different studies, that “the [National Comorbidity Survey] found that
51% of those with a lifetime addictive disorder also had a lifetime mental disorder,
compared to 38% in the [Epidemiological Catchment Area]”).
131. Watkins et al., A National Survey, supra note 130, at 1062.
132. Brady & Sinha, supra note 16, at 1484 (noting that “[s]everal theories have been
proposed to explain the high co-occurrence”).
133. Watkins et al., A National Survey, supra note 130, at 1062.
134. Jeffrey G. Johnson et al., Association Between Cigarette Smoking and Anxiety
Disorders During Adolescence and Early Adulthood, 284 [J]AMA 2348, 2350 (2000) (“Our
findings are consistent with research suggesting that cigarette smoking may increase risk
for certain anxiety disorders.”); see also George C. Patton et al., Cannabis Use And Mental
Health in Young People: Cohort Study, 325 BRIT. MED. J. 1195, 1198 (2002) (“[F]requent
use of cannabis in young people increases the risks of later depression and anxiety.”); Paul
Rhode et al., Natural Course of Alcohol Use Disorders from Adolescence to Young
Adulthood, 40 J. AM. ACAD. CHILD ADOLESC. PSYCHIATRY 83, 83 (2001) (“Adolescent
[alcohol use disorder], significantly predicted [alcohol use disorder], substance use
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individuals with mood disorders135—individuals may first develop a
mental illness and begin using addictive substances as a means of
treating the symptoms of those disorders, a practice commonly
referred to as “self-medicating.”136 In the majority of cases, however,
“the temporal relationships between the disorders and the high
proportion of primary lifetime conditions suggest that most of them
are primary independent disorders—that is, one did not cause the
other.”137
While rates of co-occurring mental health and substance use
disorders can vary somewhat across population, substance, and type
of mental illness, they remain high and consistent within and among
groups. For instance, rates of a co-occurring substance use disorder
are high regardless of whether the individual meets diagnostic criteria
for an anxiety disorder or a mood disorder, like depression.138 Among
individuals with a current substance use disorder, about 20% also
disorder, depression, and elevated levels of antisocial and borderline personality disorder
symptoms by age 24.”); Traci L. Steuber & Fred Danner, Adolescent Smoking and
Depression: Which Comes First?, 31 ADDICTIVE BEHAVS. 133, 136 (2006) (“Results of the
analyses revealed that adolescents who smoked currently or in the past were more likely
to experience depression, with regular smokers showing the highest levels of depression,
even after controlling for previous depression.”).
135. Joel Swendsen et al., Mental Disorders as Risk Factors for Substance Use, Abuse
and Dependence: Results from the 10-Year Follow-Up of the National Comorbidity Survey,
105 ADDICTION 1117, 1125 (2010) (“The broad categories of any mood or anxiety
disorder were also associated frequently with the onset of substance dependence over the
subsequent decade.”).
136. Id. (noting that the association of a primary mental illness and an increased risk
for later substance abuse “may reflect self-medication as well as a number of other causal
mechanisms”); see also Kessler et al., supra note 130, at 28 (“[S]ubstance abuse occurs as
an unintended consequence of self-medicating a mental disorder.”); Timothy E. Wilens et
al., Further Evidence of an Association Between Adolescent Bipolar Disorder with Smoking
and Substance Use Disorders: A Controlled Study, 95 DRUG AND ALCOHOL
DEPENDENCE 188, 195 (2008) (“It may be that adolescents self medicate their irritable
mood, aggressivity, and ‘affective storms’ with substances of abuse or alcohol.”).
137. Watkins et al., A National Survey, supra note 130, at 1062. While the correlation
between mental illness and addiction can be viewed as either a high incident of mental
illness in individuals with addiction, or as a high incident of addiction in individuals with
mental illness, “both views suggest that there may be common neurobiological substrates
for substance abuse and mental disorders.” Nora D. Volkow, What Do We Know About
Drug Addiction?, 162 AM. J. PSYCHIATRY 1401, 1401 (2005); see also Brady & Sinha,
supra note 16, at 1484 (“A growing body of evidence from basic science and translational
studies implicates common neurobiological pathways and abnormalities involved in
addiction and a number of psychiatric disorders.”).
138. At any given time, approximately 19.2 million American adults meet diagnostic
criteria for a mood disorder, and 23 million meet diagnostic criteria for an anxiety
disorder. Bridget F. Grant et al., Prevalence and Co-Occurrence of Substance Use
Disorders and Independent Mood and Anxiety Disorders, 61 ARCHIVES GEN.
PSYCHIATRY 807, 814 (2004). The numbers are similar for substance use disorder, which
affects approximately 19.4 million American adults. Id.
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have an independent mood disorder, and 18% have an independent
anxiety disorder.139 Similarly, among individuals with a current mood
disorder, about 20% have a substance use disorder, and among
individuals with a current anxiety disorder, about 15% also have a
substance use disorder.140 Even higher numbers are seen in
individuals with psychotic disorders; one study of 1219 individuals
with schizophrenia, for instance, found that 54% of the participants
also met diagnostic criteria for a substance use disorder.141
Similarly, individuals with “behavioral addictions,” or
nonsubstance addictions, also have high rates of co-occurring
disorders.142 For example, a study of problem gamblers found that
57% of participants also met criteria for a substance use disorder.143 A
co-occurring substance use disorder may develop concurrently with a
gambling disorder, or an individual may use gambling as a way to
alleviate symptoms and cope “with a more general underlying
psychopathology involving a mood or anxiety disorder.”144 In still
other individuals, mood disorders are secondary symptoms that occur
in response to significant financial losses.145 But whether a substance
139. Id.
140. Id. at 814–15.
141. Berit Kerner, Comorbid Substance Use Disorders in Schizophrenia: A Latent Class
Approach, 225 PSYCHIATRY RES. 395, 397 (2015) (“Substance use disorders preceded the
onset of schizophrenia in about two-third of cases with substance use, and in about onethird of cases substance use disorders had been diagnosed after the onset of
schizophrenia.”).
142. These types of disorders are “analogous to substance addiction, but with a
behavioral focus other than ingestion of a psychoactive substance.” Jon Grant et al.,
Introduction to Behavioral Addictions, 36 AM. J. DRUG & ALCOHOL ABUSE 233, 233
(2010). Apart from gambling disorder, which the most recent edition of the DSM has
moved to a new section entitled “Non-Substance-Related Disorders,” DSM-5, supra note
83, at 585–86, these types of behaviors are typically classified as impulse control disorders,
and include things like kleptomania, Grant et al., supra, at 233. The DSM-5 also created a
separate section for “Non-Substance-Related Disorders,” which includes gambling
disorder as its only condition. Id. “Although some behavioral conditions that do not
involve ingestion of substances have similarities to substance-related disorders, only one
disorder—gambling disorder—has sufficient data to be included in this section.” DSM-5,
supra note 83, at 586. As the American Psychiatric Association notes, “[t]his new term and
its location in the new manual reflect research findings that gambling disorder is similar to
substance-related disorders in clinical expression, brain origin, comorbidity, physiology,
and treatment.” SUBSTANCE-RELATED AND ADDICTION DISORDERS, supra note 102, at
1.
143. Felicity K. Lorains et al., Prevalence of Comorbid Disorders in Problem and
Pathological Gambling: Systematic Review and Meta-Analysis of Population Surveys, 106
ADDICTION 490, 493 (2010) (noting that among problem gamblers, “57.5% [were also
diagnosed] for any substance use disorder, 28.1% for alcohol use disorder, 17.2% for illicit
drug abuse/dependence and 60.1% for nicotine dependence”).
144. Id. at 495.
145. Id.
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use disorder or other mental health disorder preceded, developed
concurrently with, or was a result of problem gambling, the research
consistently shows that individuals with gambling disorder “have high
prevalence rates for many comorbid disorders.”146
Finally, studies examining specific populations also find high
rates of co-occurring substance use and mental health disorders. For
example, one study of veterans returning from wars in Iraq and
Afghanistan found that of 103,788 users of U.S. Department of
Veterans Affairs services, 25% sought treatment for a mental health
condition, and many sought services for multiple mental health
disorders.147 Veterans most often sought services for PTSD,148 which
similarly “has a high co-occurrence with other mental health
diagnoses.”149 Among individuals with PTSD, rates of co-occurring
depression are between 48% and 60%, and rates of substance use
disorder are between 34% and 88%.150 As one author noted, “[t]hese
results indicate a large burden of co-occurring mental health disorders
associated with service in Iraq and Afghanistan.”151
These are only a few examples. A review of the literature reveals
hundreds of studies detailing high and consistent rates of co-occurring
mental health and substance use disorders, rates that hold across
disorder, substance, and population.152 Furthermore, individuals with
co-occurring disorders have higher morbidity and mortality rates, and
treatment for more than one disorder can be difficult to coordinate.153
Yet the research consistently demonstrates that integrated treatment
programs are more effective and have better outcomes for patients

146. Id. at 496.
147. Karen H. Seal et al., Bringing the War Back Home: Mental Health Disorders
Among 103,788 US Veterans Returning from Iraq and Afghanistan Seen at Department of
Veterans Affairs Facilities, 167 ARCHIVES INTERNAL MED. 476, 478 (2007) (“The median
number of different diagnoses was 3 . . . ; 44% had a single mental health diagnosis, 29%
had 2 different diagnoses, and 27% had 3 or more different mental health diagnoses.”).
148. Id. (“The single most common mental health diagnosis was PTSD . . . ,
representing 52% of those receiving mental health diagnoses.”).
149. Tracy Stecker et al., Co-Occurring Medical, Psychiatric, and Alcohol-Related
Disorders Among Veterans Returning from Iraq and Afghanistan, 51 PSYCHOSOMATICS
503, 504 (2010).
150. Id. (citing various studies).
151. Seal et al., supra note 147, at 479.
152. For an excellent review of the research literature on co-occurring disorders and
appropriate treatment, see INTEGRATED TREATMENT, supra note 125, at 1–5.
153. Katherine E. Watkins et al., Prevalence and Characteristics of Clients with CoOccurring Disorders in Outpatient Substance Abuse Treatment, 30 AM. J. DRUG &
ALCOHOL ABUSE 749, 750 (2004).
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than programs that focus on only one disorder.154 As discussed in the
next part, however, individuals with co-occurring disorders who enter
treatment often encounter a segregated treatment system—if they
encounter one at all—and few practitioners are trained in the
appropriate and effective treatment of this population.
IV. INTEGRATED TREATMENT AND BARRIERS TO TREATMENT
Although integrated dual diagnosis services and other evidencebased practices are widely advocated, they are rarely offered in
routine mental health treatment settings. The barriers are
legion.155
A recent review of twenty-six controlled studies of treatment for
co-occurring mental health and substance use disorders found that the
most effective treatments for co-occurring disorders “are integrated,
which means that they combine mental health and substance abuse
interventions at the clinical interface.”156 In an integrated treatment
setting, individuals receive appropriate mental health and substance
abuse treatment from a single clinician or clinical team.157 Because the
clinical team is responsible for providing cohesive treatment, the
individual experiences the treatment as “singular, because it entails a
consistent approach, philosophy, and set of recommendations.”158
When clinicians take responsibility for providing a cohesive set of
services to patients, mental health and substance abuse interventions
are therefore better coordinated and more accessible to patients.
Treatment within a coordinated system allows providers to
“modify[] as well as combin[e] the treatments for both disorders” in a

154. Robert E. Drake et al., Implementing Dual Diagnosis Services for Clients with
Severe Mental Illness, 52 PSYCHIATRIC SERVS. 469, 471 (2001).
155. Id. at 472–73.
156. Drake et al., A Review of Treatments, supra note 128, at 367 (“Despite enormous
variance in designs, interventions, and outcome measures, several consistent themes
appear across the studies and thus emerge as principles of care. The most consistent
finding across recent studies is that effective dual disorders treatments are integrated.”);
see also Clark et al., supra note 125, at 7 (“There is growing consensus that for COD
treatment to be effective, mental health and substance abuse interventions should be
integrated at the clinical interface.”); Susan Foster et al., Services and Supports for
Individuals with Co-Occurring Disorders and Long-Term Homelessness, 37 J. BEHAV.
HEALTH SERVS. & RES. 239, 241 (2010) (“Although the treatment field has not coalesced
to define the specific practices and interventions to serve the full range of client
populations with COD, integrated treatment for persons with severe levels of psychiatric
and substance use issues has received strong research support.”).
157. Drake et al., A Review of Treatments, supra note 128, at 367.
158. Id. (noting that in an integrated system, patients “are not required to negotiate
with separate clinical directives, teams, programs, or treatment systems”).

97 N.C. L. REV. 355 (2019)

382

NORTH CAROLINA LAW REVIEW

[Vol. 97

way that helps individuals address both conditions.159 For example,
when an individual with a serious mental illness receives substance
abuse counseling, that treatment should be “slower, less
confrontational, more repetitive, more focused on motivation, and
more behavioral than what is provided in many traditional substance
abuse treatment settings . . . .”160 Similarly, individuals who receive
pharmacological treatments for one or both disorders will often need
to be prescribed medications that pose less risk for abuse or drug
interactions.161
Despite what we know about effective and integrated treatment
for individuals with co-occurring disorders, however, a recent study
by the U.S. Department of Health and Human Services found that of
the four million American adults with a co-occurring substance use
and mental health disorder, about half of them received some type of
treatment, either for substance use or mental illness, but only 11.8%
received treatment for both conditions.162 Another study put the
number slightly lower, finding that “[d]espite the recommendation
that individuals who have co-occurring disorders receive treatment
for both their mental health and substance use problems, only 8
percent received either integrated or parallel treatment.”163 Not
surprisingly, treatment rates are lowest in traditionally underserved
groups, including people with low incomes and no health insurance,
elderly people, racial and ethnic minorities, and people in rural
areas.164
Part of the reason for low rates of integrated treatment stems
from the bifurcation of mental health and addiction services, a divide
159. Id. at 367.
160. Id. (recognizing “the special needs of many individuals with severe mental
illnesses”).
161. See Jean-Michel Azorin et al., Pharmacological Treatment of Schizophrenia with
Comorbid Substance Use Disorder, 17 EXPERT OPINION ON PHARMACOTHERAPY 231,
231–32 (2016); Lana A. Vornik et al., Management of Comorbid Bipolar Disorder and
Substance Abuse, 67 J. CLINICAL PSYCHIATRY 24, 24–26 (2006).
162. EPSTEIN ET AL., U.S. DEP’T OF HEALTH & HUM. SERVS., SERIOUS MENTAL
ILLNESS AND ITS CO-OCCURRENCE WITH SUBSTANCE USE DISORDERS 2–3 (2002),
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.361.9429&rep=rep1&type=pdf
[https://perma.cc/Y2UW-J3X7].
163. Watkins et al., A National Survey, supra note 130, at 1066; see also Clark et al.,
supra note 125, at 6 (finding that of the 5.2 million American adults identified as having
co-occurring substance use and mental health disorders, “[o]nly 8.5% received treatment
for both their mental health and substance use problems”); Foster et al., supra note 156, at
240.
164. Clark et al., supra note 125, at 5 (citing Wang et al., Twelve-Month Use of Mental
Health Services in the United States: Results from the National Comorbidity Survey
Replication, 62 ARCHIVES GEN. PSYCHIATRY 629, 629 (2005)).

97 N.C. L. REV. 355 (2019)

2019]

ABOUT A REVOLUTION

383

one author describes as “two distinct and heavily bounded
territories.”165 Instead of receiving treatment for both conditions,
individuals with co-occurring disorders “tend to be assigned to one
system or the other, which would view them through its own
particular lens . . . .”166 This divide between mental health and
addiction services has created structural barriers to integrated
treatment that can prevent or reduce the likelihood that people with
both addiction and mental illness will receive care.167 In particular,
individuals seeking treatment for a co-occurring mental health and
substance use disorder are often unable to find providers in their
geographic area or are unable to find providers trained in the
integrated treatment of co-occurring disorders.
Many individuals who need treatment for a co-occurring mental
illness and substance use disorder are simply unable to find or access
available services. This lack of services is particularly pronounced in
rural areas, where “medical providers . . . often fail to address cooccurring disorders . . . .”168 Even in larger areas, however, there are
few available treatment providers for co-occurring disorders and few
residential or rehabilitation programs geared toward individuals with
co-occurring disorders.169 A recent study interviewed clinicians with
experience in treating patients with co-occurring substance use and
mental health disorders, many of whom “expressed frustration about
the lack of integrated psychiatric and substance use treatment, and
patients falling into the gap between the two services.”170

165. Davidson & White, supra note 18, at 110 (describing the “importance of providing
integrated care for persons with co-occurring disorders” and obstacles to integration that
range from “historical, political, ideological, professional, and fiscal/structural issues at one
end of the spectrum . . . to practical and logistical issues at the other end”).
166. Robert E. Drake et al., A Systematic Review of Psychosocial Research on
Psychosocial Interventions for People with Co-Occurring Severe Mental and Substance Use
Disorders, 34 J. SUBSTANCE ABUSE TREATMENT 123, 123 (2008) (noting that “[s]uch
problems continue in the fragmented U.S. healthcare system”).
167. Priester et al., supra note 3, at 56.
168. Ronald D. Hester, Integrating Behavioral Health Services in Rural Primary Care
Settings, 25 SUBSTANCE ABUSE 63, 63 (2004) (“Substance abuse and mental health
services treatment options in small towns are often very limited.”). Furthermore, many
individuals in rural areas have little access to transportation, making it even more difficult
to access services. Priester et al., supra note 3, at 55 (“Geographic proximity to services
and lack of transportation or resources to obtain transportation to reach these limited
services are commonly cited in the literature as a barrier to treatment access.”).
169. Id. at 55 (“A primary barrier to treatment access for individuals with COD is
service availability.”).
170. Kate B. Carey et al., Treating Substance Abuse in the Context of Severe and
Persistent Mental Illness: Clinicians’ Perspectives, 19 J. SUBSTANCE ABUSE TREATMENT
189, 195 (2000). As one clinician noted,
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Other clinicians identified a need for more training for health
care professionals who work with individuals with co-occurring
disorders.171 Mental health treatment providers and substance use
treatment providers receive vastly different types of training,
“probably because health care professionals often were not interested
in treating addiction problems,”172 and few receive training in both
fields.173 Many addiction treatment providers have little or no medical
training, and in many cases their only qualification is a personal
history of addiction.174 Even among medical doctors, “most
psychiatric programs do not provide training in co-morbid disorders
and many family practice residents do not feel confident in discussing
substance use issues with their patients.”175 And while medical schools

[W]e’re not a substance abuse treatment center so that when we’re doing this
work, it’s over and above the mental health treatment. And [it involves] resource
stretching. . . . Oh, yeah, let’s add this other layer of treatment that we’re not
licensed for, we don’t get paid for. . . . That makes it tough.
Id. (alterations in original); see also Watkins et al., A National Survey, supra note 130, at
1062 (“Substance abuse and mental health treatment programs are funded and managed
separately, and coordination of treatment regimens across established bureaucracies has
been difficult.”).
171. Even among clinicians with experience in treating this population, much of the
training they have received is informal. As one person in the Carey study stated, “One
[method] is taking a lot of workshops and courses. . . . The other [method] is investment in
my own recovery and doing a lot of reading in the area and thinking about it. And third is
just experience and just trying to keep my own eyes open.” Carey et al., supra note 170, at
192.
172. Mary Louise E. Kerwin et al., Comparative Analysis of State Requirements for the
Training of Substance Abuse and Mental Health Counselors, 30 J. SUBSTANCE ABUSE
TREATMENT 173, 173 (2006); see also Dackis & O’Brien, supra note 84, at 1431
(“Pejorative views toward addictive individuals also exist and contribute to policies that
would be simply unacceptable if applied to ‘real’ medical disorders.”); Elizabeth H.
Hawkins, A Tale of Two Systems: Co-Occurring Mental Health and Substance Abuse
Disorders Treatment for Adolescents, 60 ANN. REV. PSYCHOL. 197, 204 (2009)
(“Traditional behavioral health treatment in this country revolves around separate and
often disconnected systems.”).
173. Hawkins, supra note 172, at 204 (“In general, conceptualizations of illness and
corresponding treatment philosophies are strikingly different, and required educational
backgrounds, training experiences, and licensing requirements vary widely between
mental health and substance abuse sectors.”).
174. NAT’L CTR. ON ADDICTION & SUBSTANCE ABUSE AT COLUMBIA UNIV., supra
note 85, at 176.
175. Priester et al., supra note 3, at 55. While the American Psychiatric Association’s
official position statement on substance use disorders recognizes that “[s]creening and
brief intervention for substance use disorders, which frequently co-occur with other
psychiatric disorders, should be a routine part of medical assessment,” AM. PSYCHIATRIC
ASS’N, POSITION STATEMENT ON SUBSTANCE USE DISORDERS ¶ 1 (2012),
https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/
Policies/Position-2012-Substance-Use-Disorders.pdf [https://perma.cc/6HA5-5A63], the
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and psychiatry programs have increased training for substance use
disorders, most still fail to address the needs of patients with cooccurring disorders.176 Finally, there are few opportunities for crosstraining and few incentives or resources for practitioners to seek out
dual certification.177 As one author noted, there are few accepted
models for co-occurring disorders specialists, and “becoming dually
certified or licensed is an onerous burden that most do not
undertake.”178
Because of this lack of cross-training among addiction treatment
and mental health care providers, there is a corresponding lack of
providers with experience in co-occurring disorders and fewer
resources available to individual patients.179 Moreover, because they
lack training in both fields, many treatment providers “may identify a
substance use disorder or a mental health disorder but not the cooccurrence of both.”180 Underidentification of co-occurring disorders
means that few patients “who could benefit from treatment receive it,
and those who do often get it after their problems are severe and cooccurring with medical and psychiatric conditions.”181
Our historically bifurcated approach toward the treatment of
mental illness and substance use disorders has therefore created
entrenched structural barriers to integrated treatment. As a result,
many individuals who attempt to access treatment for co-occurring
majority of psychiatry residencies “do not provide adequate training in the management of
complicated patients with these comorbid disorders,” John A. Renner, Jr., How to Train
Residents to Identify and Treat Dual Diagnosis Patients, 56 BIOLOGICAL PSYCHIATRY 810,
810 (2004).
176. Renner, supra note 175, at 810 (“Psychiatry training in the United States has
failed to adequately address the needs of patients with comorbid substance use disorders
(SUD) and major psychiatric disorders. . . . Medical schools rarely provide adequate
training in the management of these patients.”); Stacy Sterling et al., Access to Treatment
for Adolescents with Substance Use and Co-Occurring Disorders: Challenges and
Opportunities, 49 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 637, 641 (2010)
(noting that medical providers “rarely receive adequate training to manage [substance
use] problems, and even less to manage co-occurring problems”).
177. Hawkins, supra note 172, at 204.
178. Id.
179. Id. (“As a result, few providers at the local level are knowledgeable and capable
of treating co-occurring disorders.”).
180. Priester et al., supra note 3, at 55; see also Alan I. Green et al., Schizophrenia and
Co-Occurring Substance Use Disorder, 164 AM. J. PSYCHIATRY 402, 403 (2007) (“Cooccurring substance use disorders are often underdetected and undertreated in mental
health settings, where the traditional separation between mental health and substance
abuse training programs and service delivery systems results in a lack of knowledge about
co-occurring disorders . . . .”).
181. Sterling et al., supra note 176, at 638 (noting that “[t]hey are then more difficult to
treat, and more expensive to health care systems”).
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disorders “frequently fall through the cracks” between the two
systems.182 And while one clear barrier to integrated treatment is the
lack of trained providers, another less obvious structural barrier is the
organization—and segregation—of drug, alcohol, and mental health
courts.
Many individuals receive mental health or substance use
treatment as a result of their diversion into a specialty court. And
while these courts claim to have created a revolution in the criminal
justice system, their basic organizational structure has not kept pace
with what we now know about the appropriate—and integrated—
treatment of co-occurring mental health and substance use disorders.
As discussed in the next part, if specialty courts are to stay on the
cutting edge of criminal justice reform, they must take a bigger role in
the identification and treatment of individuals with co-occurring
disorders who are diverted out of the criminal justice system. In this
way, specialty courts can help improve the often fragmented and
confusing treatment system encountered by individuals with cooccurring mental illness and substance use disorders.
V. TOWARD INTEGRATED TREATMENT IN DRUG AND MENTAL
HEALTH COURTS
The drug court model is ubiquitous, and many individuals will
become involved in a drug or other specialty court in the United
States each year. In its most recent Census of Problem-Solving
Courts, the Department of Justice counted 3052 specialty courts in
the United States, 44% of which were drug courts and 11% of which
were mental health courts.183 Moreover, there are an additional 400
DWI and hybrid DWI/drug courts, which together comprise
approximately 13% of all specialty courts.184 Although alcohol and
DWI courts are technically distinct from drug courts, this Article uses
the general term “drug court” to encompass both traditional drug
182. Clark et al., supra note 125, at 6.
183. STRONG ET AL., supra note 26, at 1. As of the 2012 census, only Connecticut,
Kansas, Nebraska, North Dakota, Puerto Rico, Rhode Island, South Dakota, West
Virginia, and Wyoming did not have at least one mental health court. Id. at 3–4. Every
state has at least one drug court, and many states have dozens of such courts, including
California with eighty-three, Florida with sixty-eight, Missouri with sixty-two, and New
York with fifty. Id.
184. Id. at 1 fig.1 (counting 183 DWI courts and 217 hybrid DWI/drug courts). DWI
courts “focus on changing the behavior of the alcohol-dependent offender or offenders
with a high blood alcohol content who were arrested for DWI or driving under the
influence,” while hybrid DWI/drug courts “handle alcohol or drug-dependent offenders
who have also been charged with a driving offense.” Id. at 2.
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courts and these other alcohol and DWI courts, which “focus on
changing the behavior of the alcohol-dependent offender . . . .”185
Given their large numbers and diverse locations, it is not
surprising that individual specialty courts vary tremendously.186
Moreover, due in part to the many varieties of specialty courts,
individual courts employ vastly different structures and procedures,
leading some researchers to describe specialty courts as a kind of
“black box.”187 As one author noted, “when you’ve seen one mental
health court, you’ve seen one mental health court.”188 Other
researchers have suggested that the roots of the drug court
movement—which was developed by individual judges and without
an underlying theoretical model—are in some ways responsible for
this lack of consistent structure.189
This lack of uniform structure extends to the selection of
specialty court participants. While eligibility and placement
requirements are often dictated by statute, they vary tremendously
from court to court, and other aspects of the specialty court model are
far less transparent. In particular, it is difficult to ascertain the specific
procedures by which individuals are sorted into a particular specialty
court. In many jurisdictions, referral into a drug court is generally up
to the prosecutor,190 and drug courts primarily accept individuals
185. Id.
186. For an excellent overview of the history of drug courts and the similarities and
differences among various courts, see NOLAN, supra note 27, 39–60.
187. Jeff Bouffard & Faye Taxman, Looking Inside the “Black Box” of Drug Court
Treatment Services Using Direct Observations, 34 J. DRUG ISSUES 195, 195 (2004); John S.
Goldkamp, Michael D. White & Jennifer B. Robinson, Do Drug Courts Work? Getting
Inside the Drug Court Black Box, 31 J. DRUG ISSUES 27, 27 (2001); Deborah Koetzle
Shaffer, Looking Inside the Black Box of Drug Courts: A Meta-Analytic Review, 28 JUST.
Q. 493, 493 (2010).
188. Ursula Castellano & Leon Anderson, Mental Health Courts in America: Promise
and Challenges, 57 AM. BEHAV. SCI. 163, 170 (2013); see also Bean, supra note 68, at 720
(“What one finds is that there are as many variations in the locus of Drug Courts within
the legal system as there are Drug Courts themselves.”).
189. Shaffer, supra note 187, at 494–95 (2010) (“The lack of a theoretical model during
the model’s infancy, coupled with a lack of guidance on how to implement the key
components resulted in considerable inconsistency in the structure of the model across
jurisdictions.”); see also Hora et al., supra note 37, at 449 (“Few early [drug court]
practitioners worried about the jurisprudential theory behind the [drug court] movement.
[Drug courts] seemed to work, and the absence of analysis or debate coming from the
‘ivory towers’ of academia about the efficacy of drug treatment in a criminal justice setting
did not much matter.”).
190. See, e.g., People v. Sturiale, 98 Cal. Rptr. 2d 865, 867 (Cal. Ct. App. 2000) (noting
that the prosecutor has sole discretion under California law to determine eligibility for a
drug court program); State v. Upshaw, 648 So. 2d 851, 852 (Fla. Dist. Ct. App. 1995)
(noting that “the law is well settled that the State Attorney has the sole discretion to
prosecute” and “offer [the defendant] a drug court program”).
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charged with drug crimes.191 In mental health courts, however, many
referrals come from the prosecutor, but referrals may also come from
other judges, treatment providers, family members, or even staff
members at the county jail.192
An individual with a co-occurring disorder may therefore be
assigned to a mental health court or a drug court based in large part
on the crime that led to her arrest or by the source of her referral. In
many cases, however, if an individual with a co-occurring mental
health and substance use disorder is charged with a drug crime or
with driving while intoxicated, they are likely to be referred to a drug
court or a DWI court, with little attention given to the possible
presence of multiple disorders. Moreover, judges and court personnel
in these segregated courts have differing levels of expertise and
knowledge of available community resources. Specialty court
participants with co-occurring disorders may (or may not) receive
treatment for each disorder, but the focus of their rehabilitation will
in many cases depend simply on the particular specialty court they
enter. Appropriate and integrated treatment therefore becomes a
game of chance for many specialty court participants.
Perhaps mindful of the limitations of segregated specialty courts
and the high rates of co-occurring disorders, a handful of jurisdictions
have established “co-occurring disorder courts,” though these appear
to be the exception rather than the rule. Although it is difficult to
identify exact numbers, there appears to be four specialty courts
around the country that are explicitly devoted to serving individuals
with co-occurring disorders. The Jasper County, Missouri, CoOccurring Disorder Court, for example, admits defendants who “have
a mental illness and substance abuse disorder which is related to their
current charge and/or for whom mental health [and] substance abuse
treatment in a court supervised program can be expected to foster
191. U.S. DEP’T OF JUSTICE, supra note 28, at 9. Similarly, DWI and hybrid DWI/drug
courts generally accept alcohol- or drug-dependent offenders who have been charged with
a driving offense. STRONG ET AL., supra note 26, at 2.
192. See ALMQUIST & DODD, supra note 29, at 15 (citing various studies). Similarly,
“any interested party may request that a criminal case be transferred” to a Boston Mental
Health Court. W. ROXBURY DIV. OF THE BOS. MUN. COURT, RECOVERY WITH JUSTICE
PROGRAM: MENTAL HEALTH SESSION, http://www.mass.gov/courts/docs/specialty-courts/
mental-health-court-brochure.pdf [https://perma.cc/9LLG-BACP]. In other specialty courts,
referral to a particular court appears to be self-directed. In Nevada, for instance, veterans
“can be self-referred, their attorneys may refer them, or other judges and other
jurisdictions may refer them” to veterans court. Robert Horne, Nevada Veteran’s Specialty
Courts, NEV. L., Nov. 2016, at 25, 25. Signs are posted on courtroom doors asking veterans
“to please notify their public defender or attorney if they are a veteran” so the court can
be made aware of potential candidates for the Veterans Treatment Court. Id.
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recovery and reduce recidivism.”193 Similarly, Maine has created a cooccurring disorder court that admits “adults with significant substance
abuse disorders and mental illnesses and serious criminal charges.”194
The remaining two co-occurring disorder courts—in Reno,
Nevada, and Los Angeles County, California—limit eligibility to
misdemeanor and drug charges, respectively. For example, the Reno,
Nevada, Misdemeanor Co-Occurring Mental Health and Substance
Abuse Disorder Specialty Court only accepts low-level offenders,
limiting eligibility to offenders “who appeared for misdemeanor
charges and exhibited or had a previous diagnosis of a mental health
condition coupled with alcohol or other drug use . . . .”195 The Los
Angeles County Co-Occurring Disorders Court appears to be
directed toward the city’s homeless population and limits eligibility to
“non-violent felony drug offenders who have both a severe, chronic
substance abuse disorder and serious, persistent mental illness are
homeless or at risk for homelessness and have had frequent contacts
with the criminal justice system.”196 Although these courts’
recognition of individuals with co-occurring disorders is
commendable, many critics argue that this type of cherry picking of
court participants excludes individuals who would benefit most from
participation in the court197 and also discriminates against people of
color.198
193. 29TH JUDICIAL CIRCUIT, JASPER COUNTY CO-OCCURRING DISORDERS COURT
PARTICIPANT’S MANUAL 3 (2017), http://www.jaspercounty.org/pdf/courts/treatmentcourt/
CoOccuringManual.pdf [https://perma.cc/865Y-uzvl].
194. Maine Co-Occurring Disorders and Veterans Court, ST. ME. JUD. BRANCH
http://www.courts.maine.gov/maine_courts/drug/codvc.html [https://perma.cc/6WBL-Z8DD].
Even this innovative court, however, further segregates participants into two tracks:
participants are assigned to either civilian or veteran’s co-occurring disorders court, in
recognition of the fact that “criminal conduct as well as behavioral disorders may be
attributable to their service . . . .” Id.
195. KEVIN CROWE, RENO MUN. COURT, CO-OCCURRING DISORDER SPECIALTY
COURT (COD) PROGRAM EVALUATION REPORT 3 (2014), https://www.reno.gov/home/
showdocument?id=48292 [https://perma.cc/PJ8Y-PNQS].
196. CTY. OF L.A. DEP’T OF PUB. HEALTH, CO-OCCURRING DISORDERS COURT
PROGRAM FACT SHEET, http://www.publichealth.lacounty.gov/sapc/resources/CoOccurringDisorderCourt.pdf [https://perma.cc/9EJT-NNQT].
197. JUSTICE POLICY INST., supra note 24, at 21 (“Drug courts that receive federal
discretionary grants are required to focus on people accused of nonviolent offenses and
those without a violent record. Yet research shows that drug courts have the greatest
benefit for people who have more prior felony convictions and have previously failed
other dispositions.”).
198. Id. (“Since people of color are more likely to have a felony conviction on their
record at the time of an arrest related to drug abuse, they are more likely to be excluded
from consideration for drug court participation.”); see also Josh Bowers, Contraindicated
Drug Courts, 55 UCLA L. REV. 783, 807 (2008) (“Consequently, addicts, minorities, and
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Despite some of these drawbacks, however, the existence of
these few co-occurring disorder courts is one example of the progress
that we have seen in the integration of mental health and substance
use treatment systems in communities around the country. The
mental health system has begun “providing or encouraging training in
[alcohol and drug] problems for some time, and the general level of
skill of practitioners is improving.”199 At the same time, many
addiction treatment providers now have a better understanding of
how to treat individuals who have a co-occurring mental illness.200
Notwithstanding these advances, however, “[a]rtifacts of the
structural and organizational disconnect between the mental health
and substance abuse treatment systems persist.”201 Even with
increasing numbers of practitioners trained in the treatment of cooccurring disorders, structural barriers—including thousands of
segregated drug and mental health courts—prevent individuals from
receiving appropriate and integrated treatment. Better training for
practitioners, standing alone, will not create lasting improvements in
integrated treatment. As one author noted, “without structural,
regulatory, and funding changes required to reinforce training, newly
acquired expertise will not be used and will soon disappear.”202
The existing research overwhelmingly supports the propriety and
efficacy of integrated treatment for co-occurring mental health and
substance use disorders.203 Yet our current national system of
segregated and fractured treatment of individuals with co-occurring
disorders makes it more difficult for individuals to obtain appropriate
the underprivileged are terminated more frequently from drug courts, even perhaps in
circumstances where they are doing just as well (or as badly) as their white and affluent
counterparts.”); John R. Gallagher, African American Participants’ Views on Racial
Disparities in Drug Court Outcomes, 13 J. SOC. WORK PRAC. ADDICTIONS 143, 156 (2013)
(finding that minority participants in one drug court reported feeling that “it was common
in court for the audience and drug court staff to laugh” when African American
participants were given sanctions).
199. Joan E. Zweben, Severely and Persistently Mentally Ill Substance Abusers: Clinical
and Policy Issues, 32 J. PSYCHOACTIVE DRUGS 383, 384 (2000); see also Clark et al., supra
note 125, at 7 (“Although mental health and substance abuse treatment systems have
historically been separate, the mental health system has been providing and encouraging
more training on substance use disorders, and addiction treatment providers are increasing
their capacity to deal with clients who have mental disorders.”).
200. Zweben, supra note 199, at 384 (“More and more addiction treatment providers
are developing the capability of dealing with a population that has thought disorders for
periods of time.”).
201. Clark et al., supra note 125, at 7.
202. Id. (“Even when qualified and well-trained clinicians are available, however,
evidence suggests that training alone is not sufficient to sustain changes in clinical practice
that are needed to promote integrated care.”).
203. See supra Part IV.
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treatment and reduces the efficacy of the treatment that individuals
do receive. Our system of treatment must be integrated to improve
accessibility and the quality of treatment for individuals with cooccurring disorders. Similarly, “[s]creening and referral must become
routine so that mental and substance use disorders receive equal
treatment.”204 The integration of drug, alcohol, and mental health
courts would improve the treatment received by individuals who are
diverted into specialty courts and correspondingly increase courts’
ability to “reach people who have co-occurring mild to moderate
mental and substance use disorders before their conditions become
more severe.”205
In an integrated treatment setting, individuals receive
appropriate mental health and substance use treatment from a single
clinician or clinical team.206 Specialty courts already embrace this
team approach to treating individuals. In the specialty court model,
the judge approaches each case as the leader of a team that includes
prosecutors, probation officers, defense attorneys, and social
workers.207 The team creates a treatment plan that the defendant must
agree to. Defendants participate in a variety of treatments, but those
treatments are focused differently in different specialty courts.208 For
example, drug courts “handle an underlying drug problem
contributing to criminal behavior . . . .”209 In drug court, “the goal
remains consistent—drug treatment for addicted drug offenders
instead of incarceration and/or probation.”210 Similarly, alcohol and
DWI courts “focus on changing the behavior of the alcoholdependent offender . . . .”211 Mental health courts, in contrast, divert
defendants
into
“judicially
supervised,
community-based

204. Clark et al., supra note 125, at 6.
205. Id.
206. Drake et al., A Review of Treatments, supra note 128, at 367.
207. Edgely, supra note 35, at 572 (“A judge supervises a multi-disciplinary team that
determines the most appropriate interventions for the offender, who is required to report
back to the court at periodic status hearings.”). The judge and court personnel typically
meet to review cases prior to status hearings with defendants. The team often includes
prosecutors and defense attorneys, probation officers, and service providers. STRONG ET
AL., supra note 26, at 9.
208. Id. at 9.
209. Id. at 2.
210. Hora et al., supra note 37, at 453.
211. STRONG ET AL., supra note 26, at 2.
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treatment”212 and have the stated goal of connecting participants to
available community resources.213
The integration of drug, alcohol, and mental health courts would
allow courts to tailor treatment plans to address co-occurring
disorders simultaneously, which would ideally include “case
management, vocational rehabilitation services, family counseling,
housing, and medications.”214 Although many segregated specialty
courts provide some or all of these services, most do not provide them
with the explicit goal of addressing both disorders concurrently,
resulting in inadequate treatment for both disorders. Moreover, the
integration of segregated specialty courts would provide more
opportunities for specialty court judges and court personnel to be
appropriately trained in the screening and appropriate treatment of
individuals with co-occurring mental health and substance use
disorders.
The literature on co-occurring disorders makes it
overwhelmingly clear that individuals with co-occurring disorders
“frequently fall through the cracks between the mental health and
substance abuse treatment systems, are shuttled between systems that
can only treat one type of disorder, or receive simultaneous care from
clinicians in segregated treatment systems that do not have the
capacity to share information.”215 This results in lower rates of
treatment and poor treatment outcomes. Specialty courts, individual
judges, and policymakers can take part in addressing this challenge by
considering the integration of mental health and drug courts, which
will allow the specialty court model to better adapt to our current
understanding about the appropriate and integrated treatment of cooccurring mental health and substance use disorders.
While the integration of drug and mental health courts would be
one step toward addressing these structural barriers to the
appropriate treatment for co-occurring disorders, courts cannot take
212. Id.
213. ALMQUIST & DODD, supra note 29, at 2 (describing a variety of goals for mental
health courts, including goals “to improve public safety by reducing the recidivism rates of
people with mental illnesses, to reduce corrections costs by providing alternatives to
incarceration, and to improve the quality of life of people with mental illnesses by
connecting them with treatment and preventing re-involvement in the criminal justice
system”); see also, e.g., Mental Health Court Explained, COUNSELING WASH.,
https://www.counselingwashington.com/FAQS/Mental-Health-Court-Explained/ [https://perma.cc/
GS99-GTHS] (“[T]he goal is . . . improved access to public mental health treatment services
. . . .”).
214. Lana A. Vornik & E. Sherwood Brown, Management of Comorbid Bipolar
Disorder and Substance Abuse, 67 J. CLINICAL PSYCHIATRY 24, 28 (2006).
215. Clark et al., supra note 125, at 66.
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on this task alone. As noted above, there is a significant lack of crosstraining in both mental health and substance abuse fields, and
educational and training programs must be improved to address the
specific challenges posed by this population.216 But the current
organizational model of segregated specialty courts only exacerbates
the challenge of appropriately treating individuals with co-occurring
disorders. This lack of coordinated treatment “results in high
recidivism, poor retention, poor treatment outcomes, and increased
burden, not only for persons in need of care but also for service
delivery systems.”217
Finally, it is important that legislators and other policymakers be
informed about the prevalence and appropriate treatment of
individuals with co-occurring mental health and substance use
disorders. States and the federal government continue to allocate
hundreds of millions of dollars annually to the establishment and
support of specialty courts.218 A better understanding of the efficacy
of integrated treatment for co-occurring disorders can help guide
legislators and policymakers as they look for ways to make “scarce
dollars do more for a population known for the high cost of its
treatment . . . .”219
CONCLUSION
Specialty courts claim to have created a revolution in criminal
justice, and, indeed, these diversionary programs do represent an
important improvement. But the existing specialty court model,
where individuals are segregated into drug, alcohol, or mental health
courts, is contrary to the literature on both the disease of addiction
and the prevalence of co-occurring substance use and mental health
disorders. Moreover, segregated specialty courts are yet another
barrier to the widespread acceptance of addiction as a brain disease,
one that should be evaluated and treated like any other mental health
disorder.
216. Hawkins, supra note 172, at 217 (“A significant barrier to the provision of
integrated services is a lack of cross-training in both mental health and substance abuse
fields. Educational and training programs can begin to address this by offering courses on
co-occurring disorders and by providing clinical opportunities to work with this
population.”); see also supra Part IV.
217. Foster et al., supra note 156, at 240.
218. Due to the large number of drug and mental health courts and their geographical
diversity, it is difficult to identify precisely how much funding is received by these
individual courts. One recent study, however, found that drug courts spent approximately
$515 million per year on treatment. BHATI ET AL., supra note 50, at xi–xii.
219. Clark et al., supra note 125, at 3.
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Drug, alcohol, and mental health courts should be integrated,
both in recognition that substance abuse is a mental illness and not a
crime and because co-occurring disorders in specialty court
participants should be expected and appropriately treated. Specialty
court judges, staff, and policymakers should similarly become better
educated about advances in the research and integrated treatment of
co-occurring disorders. Perhaps most importantly, by providing
integrated treatment to specialty court participants, courts and
policymakers can dramatically improve treatment outcomes for
individuals who are diverted out of the criminal justice system and
into a specialty court.

